activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	268220	CHEMBL654964	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	Clc1ccc(-c2csc(Nc3ccccc3)n2)cc1		CHEMBL68504		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
Not Active	268220	CHEMBL654964	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	Clc1ccc(-c2csc(Nc3ccccc3)n2)cc1		CHEMBL68504		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
Not Active	268238	CHEMBL654966	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	C/C(CCS(=O)(=O)c1ccccc1)=N\OC/C=C/Cl		CHEMBL67105		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
	269719	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	COC(=O)c1ccc(/C=C/c2ccc([N+](=O)[O-])o2)o1		CHEMBL68409	=	Inhibition	%	88.4	CHEMBL4079	Homo sapiens	Inhibition	%	88.4
	269720	CHEMBL654962	Inhibition of Beta-adrenergic receptor kinase 1	B	COC(=O)c1ccc(/C=C/c2ccc([N+](=O)[O-])o2)o1	Outside typical range	CHEMBL68409	=	IC50	nM	126000.0	CHEMBL4079	Homo sapiens	IC50	uM	126.0
	270914	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	O=C(NCc1ccco1)c1ccc([N+](=O)[O-])o1		CHEMBL305469	=	Inhibition	%	37.7	CHEMBL4079	Homo sapiens	Inhibition	%	37.7
Not Active	272231	CHEMBL654966	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	CCCCCCCCCCCCCCCCN(C)c1ccc(S(C)(=O)=O)cc1N		CHEMBL70098		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
	274561	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	O=C1C(O)=C(O)O[C@H]1C1COC2(CCCCC2)O1		CHEMBL308213	=	Inhibition	%	20.4	CHEMBL4079	Homo sapiens	Inhibition	%	20.4
	274562	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	Oc1nnc(Cc2ccc(-c3ccccc3Cl)o2)c2ccccc12		CHEMBL538664	=	Inhibition	%	67.3	CHEMBL4079	Homo sapiens	Inhibition	%	67.3
	275780	CHEMBL654963	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	NC(=O)Cc1c(N)ncn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL307533	=	Inhibition	%	60.7	CHEMBL4079	Homo sapiens	Inhibition	%	60.7
	275781	CHEMBL654962	Inhibition of Beta-adrenergic receptor kinase 1	B	NC(=O)Cc1c(N)ncn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL307533	=	IC50	nM	557000.0	CHEMBL4079	Homo sapiens	IC50	uM	557.0
	277152	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	Cc1ccc(Cl)cc1NCN1C(=O)CNC1=S		CHEMBL303634	=	Inhibition	%	26.5	CHEMBL4079	Homo sapiens	Inhibition	%	26.5
Not Active	280711	CHEMBL654966	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	COc1ccc(/C=N/c2ccc(O)cc2)cc1		CHEMBL67238		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
Not Active	288997	CHEMBL654966	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	O=[N+]([O-])c1ccccc1/N=C/c1ccc2c(c1)OCO2		CHEMBL67767		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
Not Active	290246	CHEMBL654964	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	CC(C)Sc1nc2sccn2c1/C=N/OCc1c(Cl)cccc1Cl		CHEMBL69416		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
	291355	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	O=C1C(O)=C(O)O[C@@H]1C1COC2(CCCCC2)O1		CHEMBL306209	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	Inhibition	%	0.0
Not Active	292658	CHEMBL654964	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	Cc1csc(-c2nc(-c3ccc(Cl)cc3)no2)c1Cl		CHEMBL69961		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
	293855	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	CC(=O)CC(=O)Nc1cc(C(C)(C)C)sc1C(N)=O		CHEMBL68603	=	Inhibition	%	37.3	CHEMBL4079	Homo sapiens	Inhibition	%	37.3
	295252	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	Nc1nc(O)c2ncn([C@H]3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]3O)c2n1		CHEMBL2373326	=	Inhibition	%	24.2	CHEMBL4079	Homo sapiens	Inhibition	%	24.2
Not Active	296509	CHEMBL654966	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM (Inactive)	B	O=C(Nc1ccc(F)c([N+](=O)[O-])c1)Nc1cccc2c(O)cccc12		CHEMBL303439		Inhibition	%		CHEMBL4079	Homo sapiens	Inhibition	%	
	296510	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	COC(=O)c1sccc1Oc1ccc(C(F)(F)F)cc1NC=C(C#N)C#N		CHEMBL303653	=	Inhibition	%	28.8	CHEMBL4079	Homo sapiens	Inhibition	%	28.8
	297819	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	NC(=O)c1ncn([C@@H]2O[C@@H](CO)[C@H](O)[C@@H]2O)n1		CHEMBL66611	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	Inhibition	%	0.0
	300398	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	CCOC(=O)c1cnc2c(C(F)(F)F)cccc2c1O		CHEMBL68141	=	Inhibition	%	20.1	CHEMBL4079	Homo sapiens	Inhibition	%	20.1
	302843	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	CCC(=O)n1nc2c(c1C(C)(C)C)C(=O)c1ccccc1-2		CHEMBL69467	=	Inhibition	%	52.7	CHEMBL4079	Homo sapiens	Inhibition	%	52.7
	302844	CHEMBL654962	Inhibition of Beta-adrenergic receptor kinase 1	B	CCC(=O)n1nc2c(c1C(C)(C)C)C(=O)c1ccccc1-2	Outside typical range	CHEMBL69467	=	IC50	nM	563000.0	CHEMBL4079	Homo sapiens	IC50	uM	563.0
	303910	CHEMBL654965	Inhibition of Beta-adrenergic receptor kinase 1 at 1 mM	B	CC(C)COC(=O)CSc1nc2c(c(=O)[nH]c(=O)n2C)n1C		CHEMBL553567	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	Inhibition	%	0.0
	1232530	CHEMBL679594	Inhibition of G-protein coupled receptor kinase 2 (GRK2) in vitro phosphorylation	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	1233673	CHEMBL679593	Inhibition of G-protein coupled receptor kinase 2 (GRK2) in vitro phosphorylation	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
Not Determined	1246869	CHEMBL679595	Inhibition of G-protein coupled receptor kinase 2 (GRK2) in vitro phosphorylation (Not tested)	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735		NT			CHEMBL4079	Homo sapiens	NT		
	1248129	CHEMBL679594	Inhibition of G-protein coupled receptor kinase 2 (GRK2) in vitro phosphorylation	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	2200729	CHEMBL946636	Inhibition of beta-adrenergic receptor kinase	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL101892	=	Ki	nM	67000.0	CHEMBL4079	Homo sapiens	Ki	uM	67.0
	2512036	CHEMBL970559	Inhibition of GRK2 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	8.0	CHEMBL4079	Homo sapiens	INH	%	8.0
	3052618	CHEMBL1037594	Residual activity of GRK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	85.0	CHEMBL4079	Homo sapiens	Residual activity	%	85.0
	3053927	CHEMBL1046819	Residual activity of GRK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	53.0	CHEMBL4079	Homo sapiens	Residual activity	%	53.0
	3054179	CHEMBL1040647	Residual activity of GRK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	95.0	CHEMBL4079	Homo sapiens	Residual activity	%	95.0
	3055466	CHEMBL1037594	Residual activity of GRK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	105.0	CHEMBL4079	Homo sapiens	Residual activity	%	105.0
	3056771	CHEMBL1046819	Residual activity of GRK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	58.0	CHEMBL4079	Homo sapiens	Residual activity	%	58.0
	3057023	CHEMBL1040647	Residual activity of GRK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL4079	Homo sapiens	Residual activity	%	95.0
	3058343	CHEMBL1037594	Residual activity of GRK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL4079	Homo sapiens	Residual activity	%	97.0
	3058595	CHEMBL1046819	Residual activity of GRK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	73.0	CHEMBL4079	Homo sapiens	Residual activity	%	73.0
	3072941	CHEMBL1040647	Residual activity of GRK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL4079	Homo sapiens	Residual activity	%	89.0
	3212630	CHEMBL1106956	Inhibition of GRK2-mediated bovine tubulin phosphorylation by scintillation counting	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	42.0	CHEMBL4079	Homo sapiens	IC50	nM	42.0
	3224751	CHEMBL1102592	Inhibition of GRK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4079	Homo sapiens	INH	%	50.0
	3225000	CHEMBL1102592	Inhibition of GRK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4079	Homo sapiens	INH	%	50.0
	3443334	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	6.0	CHEMBL4079	Homo sapiens	INH	%	6.0
	3443551	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	6.0	CHEMBL4079	Homo sapiens	INH	%	6.0
	3444706	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	4.0	CHEMBL4079	Homo sapiens	INH	%	4.0
	3445330	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL4079	Homo sapiens	INH	%	4.0
	3445547	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	10.0	CHEMBL4079	Homo sapiens	INH	%	10.0
	3445765	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	7.0	CHEMBL4079	Homo sapiens	INH	%	7.0
	3445955	CHEMBL1243986	Inhibition of GRK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	1.0	CHEMBL4079	Homo sapiens	INH	%	1.0
	3463167	CHEMBL1251627	Inhibition of ADRBK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	4.0	CHEMBL4079	Homo sapiens	INH	%	4.0
	3463386	CHEMBL1251627	Inhibition of ADRBK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	8.0	CHEMBL4079	Homo sapiens	INH	%	8.0
	3463930	CHEMBL1251627	Inhibition of ADRBK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	15.0	CHEMBL4079	Homo sapiens	INH	%	15.0
active	6725960	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(Cl)cc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1538897	=	EC50	nM	778.9	CHEMBL4079	Homo sapiens	EC50	uM	0.7789
active	6725961	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)cc1)NCCc1ccc(Cl)cc1		CHEMBL1469482	=	EC50	nM	7058.0	CHEMBL4079	Homo sapiens	EC50	uM	7.058
active	6725962	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(NC(=O)CCS(=O)(=O)c2ccc(Br)s2)cc1		CHEMBL1411384	=	EC50	nM	9140.0	CHEMBL4079	Homo sapiens	EC50	uM	9.14
active	6725963	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1cc(O)nc(SCC(=O)NCc2ccco2)n1		CHEMBL1576239	=	EC50	nM	44940.0	CHEMBL4079	Homo sapiens	EC50	uM	44.94
inactive	6725964	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOc1ccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL1397291		EC50	nM	276.9	CHEMBL4079	Homo sapiens	EC50	uM	0.2769
active	6725965	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)s1		CHEMBL1412343	=	EC50	nM	6840.0	CHEMBL4079	Homo sapiens	EC50	uM	6.84
active	6725966	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(CNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL1730248	=	EC50	nM	3004.0	CHEMBL4079	Homo sapiens	EC50	uM	3.004
active	6725967	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCN(CC)c1ccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)c(C)c1		CHEMBL1371301	=	EC50	nM	426.2	CHEMBL4079	Homo sapiens	EC50	uM	0.4262
inactive	6725968	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOc1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1OCC		CHEMBL1508372		EC50	nM	17730.0	CHEMBL4079	Homo sapiens	EC50	uM	17.73
active	6725969	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CSc1nc2ccccc2c(=O)n1-c1ccccc1)NC(=O)CN1CCCC1=O		CHEMBL1581471	=	EC50	nM	2960.0	CHEMBL4079	Homo sapiens	EC50	uM	2.96
active	6725970	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1OC		CHEMBL1450321	=	EC50	nM	14920.0	CHEMBL4079	Homo sapiens	EC50	uM	14.92
active	6725971	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)cc1)Nc1ccc(Br)cc1F		CHEMBL1462597	=	EC50	nM	21160.0	CHEMBL4079	Homo sapiens	EC50	uM	21.16
active	6725972	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COC(=O)c1ccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL1548937	=	EC50	nM	6564.0	CHEMBL4079	Homo sapiens	EC50	uM	6.564
active	6725973	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)cc1)Nc1cc(F)ccc1F		CHEMBL1456007	=	EC50	nM	2465.0	CHEMBL4079	Homo sapiens	EC50	uM	2.465
inactive	6725974	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1cccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)c1		CHEMBL1386974		EC50	nM	22250.0	CHEMBL4079	Homo sapiens	EC50	uM	22.25
active	6725975	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CC(CS(=O)(=O)c1ccc2c(c1)NC(=O)CS2)C(=O)NCc1ccccc1Cl		CHEMBL1611255	=	EC50	nM	638.3	CHEMBL4079	Homo sapiens	EC50	uM	0.6383
active	6725976	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1432539	=	EC50	nM	3481.0	CHEMBL4079	Homo sapiens	EC50	uM	3.481
active	6725977	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1cccc(N2CCN(C(=O)CCS(=O)(=O)c3ccc(Br)cc3)CC2C)c1		CHEMBL1390068	=	EC50	nM	1997.0	CHEMBL4079	Homo sapiens	EC50	uM	1.997
active	6725978	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)C1CC(c2ccc(F)cc2)=NO1		CHEMBL1386120	=	EC50	nM	1540.0	CHEMBL4079	Homo sapiens	EC50	uM	1.54
active	6725979	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)cc1)NCCC1=CCCCC1		CHEMBL1332762	=	EC50	nM	7996.0	CHEMBL4079	Homo sapiens	EC50	uM	7.996
active	6725980	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc([N+](=O)[O-])cc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1325203	=	EC50	nM	1453.0	CHEMBL4079	Homo sapiens	EC50	uM	1.453
active	6725981	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)Cc1ccc(-n2cccc2)cc1		CHEMBL258756	=	EC50	nM	3206.0	CHEMBL4079	Homo sapiens	EC50	uM	3.206
active	6725982	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C#CCSc1nc2sc3c(c2c(=O)n1C)CCC3		CHEMBL1424086	=	EC50	nM	2718.0	CHEMBL4079	Homo sapiens	EC50	uM	2.718
active	6725983	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1438650	=	EC50	nM	337.2	CHEMBL4079	Homo sapiens	EC50	uM	0.3372
active	6725984	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)s1)Nc1ccccc1Br		CHEMBL1346073	=	EC50	nM	20880.0	CHEMBL4079	Homo sapiens	EC50	uM	20.88
active	6725985	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1484530	=	EC50	nM	11430.0	CHEMBL4079	Homo sapiens	EC50	uM	11.43
active	6725986	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL467373	=	EC50	nM	1206.0	CHEMBL4079	Homo sapiens	EC50	uM	1.206
active	6725987	CHEMBL1794478	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Powder Set1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CCS(=O)(=O)c1ccc(Br)cc1)NCc1cccs1		CHEMBL1487253	=	EC50	nM	1788.0	CHEMBL4079	Homo sapiens	EC50	uM	1.788
active	6735608	CHEMBL1794434	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL467373	=	EC50	nM	5200.0	CHEMBL4079	Homo sapiens	EC50	uM	5.2
active	6735609	CHEMBL1794434	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCc1cccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)c1		CHEMBL1349044	=	EC50	nM	6250.0	CHEMBL4079	Homo sapiens	EC50	uM	6.25
active	7348412	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CC(CS(=O)(=O)c1ccc2c(c1)NC(=O)CS2)C(=O)NCc1ccccc1Cl		CHEMBL1611255	=	EC50	nM	7530.0	CHEMBL4079	Homo sapiens	EC50	uM	7.53
inactive	7348413	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=S(=O)([O-])c1cc(O)c2c(O)c(N=Nc3cc(Cl)ccc3O)c(S(=O)(=O)[O-])cc2c1.[Na+].[Na+]		CHEMBL2028186	=	EC50	nM	16290.0	CHEMBL4079	Homo sapiens	EC50	uM	16.29
inactive	7348414	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)c1cccc2c1NC(C(=O)O)C1CC(Sc3ccccc3[N+](=O)[O-])C(Cl)C21		CHEMBL1399331	=	EC50	nM	19360.0	CHEMBL4079	Homo sapiens	EC50	uM	19.36
inactive	7348415	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@H](C(N)=O)N(C(=O)c2ccccc2)C3)c1		CHEMBL1330464	=	EC50	nM	12500.0	CHEMBL4079	Homo sapiens	EC50	uM	12.5
active	7348416	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCCCCC(=O)Nc1cccc(C2=NOC3(C2)C[C@@H](C(N)=O)N(C(=O)c2ccc(OC)cc2)C3)c1		CHEMBL1720987	=	EC50	nM	4380.0	CHEMBL4079	Homo sapiens	EC50	uM	4.38
inactive	7348417	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1cc(O)nc(SCC(=O)NCc2ccco2)n1		CHEMBL1576239	=	EC50	nM	22080.0	CHEMBL4079	Homo sapiens	EC50	uM	22.08
inactive	7348418	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOC(=O)C(C)Sc1nc2c(c(=O)[nH]c(=O)n2C)n1C/C=C(/C)Cl		CHEMBL1307459	=	EC50	nM	22130.0	CHEMBL4079	Homo sapiens	EC50	uM	22.13
active	7348419	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOC(=O)C(C)N1C(=O)S/C(=C\c2ccc(-c3ccccc3C(=O)O)o2)C1=O		CHEMBL1443718	=	EC50	nM	3050.0	CHEMBL4079	Homo sapiens	EC50	uM	3.05
inactive	7348420	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc([N+](=O)[O-])cc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1		CHEMBL1325203	=	EC50	nM	14960.0	CHEMBL4079	Homo sapiens	EC50	uM	14.96
active	7348421	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@@H](C(N)=O)N(C(=O)CCCCC)C3)c1		CHEMBL1517799	=	EC50	nM	110.0	CHEMBL4079	Homo sapiens	EC50	uM	0.11
active	7348422	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCN(CC)c1ccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)c(C)c1		CHEMBL1371301	=	EC50	nM	5010.0	CHEMBL4079	Homo sapiens	EC50	uM	5.01
inactive	7348423	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@H](C(N)=O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)c1		CHEMBL1459778	=	EC50	nM	85900.0	CHEMBL4079	Homo sapiens	EC50	uM	85.9
active	7348424	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1ccc(NC(=O)CN2C(=O)N/C(=C/c3cccn3-c3ccc(C(=O)O)cc3)C2=O)cc1		CHEMBL1427775	=	EC50	nM	1210.0	CHEMBL4079	Homo sapiens	EC50	uM	1.21
active	7348425	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1cc2ccccc2n1CCNC(=O)c1cccs1		CHEMBL1483857	=	EC50	nM	3500.0	CHEMBL4079	Homo sapiens	EC50	uM	3.5
active	7348426	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)C1CCCCC1C(=O)Nc1cccc(Br)c1		CHEMBL1435218	=	EC50	nM	3850.0	CHEMBL4079	Homo sapiens	EC50	uM	3.85
inactive	7348427	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	Cc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)s1		CHEMBL1412343	=	EC50	nM	11120.0	CHEMBL4079	Homo sapiens	EC50	uM	11.12
inactive	7348428	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCc1cccc(NC(=O)CCS(=O)(=O)c2ccc(Br)cc2)c1		CHEMBL1349044	=	EC50	nM	58340.0	CHEMBL4079	Homo sapiens	EC50	uM	58.34
inactive	7348429	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C([O-])c1ccccc1-c1c2cc(I)c(=O)c(I)c-2oc2c(I)c([O-])c(I)cc12.[Na+].[Na+]		CHEMBL2028187	=	EC50	nM	14690.0	CHEMBL4079	Homo sapiens	EC50	uM	14.69
active	7348430	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@@H](C(N)=O)N(C(=O)CC(c2ccccc2)c2ccccc2)C3)c1		CHEMBL1518604	=	EC50	nM	1940.0	CHEMBL4079	Homo sapiens	EC50	uM	1.94
active	7348431	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCCN(C(=O)c1cccc(-n2cccc2)c1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O		CHEMBL1562896	=	EC50	nM	720.0	CHEMBL4079	Homo sapiens	EC50	uM	0.72
inactive	7348432	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)Cc1ccc(-n2cccc2)cc1		CHEMBL258756	=	EC50	nM	36220.0	CHEMBL4079	Homo sapiens	EC50	uM	36.22
inactive	7348433	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CC1=NN(c2cccc(C(=O)O)c2)C(=O)/C1=C\C=C\c1ccco1		CHEMBL1373655	=	EC50	nM	14790.0	CHEMBL4079	Homo sapiens	EC50	uM	14.79
inactive	7348434	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)c1c2c(nc3ccccc13)/C(=C/c1ccc(O)cc1)CC2		CHEMBL1563317	=	EC50	nM	33270.0	CHEMBL4079	Homo sapiens	EC50	uM	33.27
inactive	7348435	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)C1CC(=O)N(c2ccc3c(c2)OCCO3)C1		CHEMBL1602152	=	EC50	nM	30900.0	CHEMBL4079	Homo sapiens	EC50	uM	30.9
active	7348436	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)C(c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1.[Na+]		CHEMBL1343544	=	EC50	nM	70.0	CHEMBL4079	Homo sapiens	EC50	uM	0.07
active	7348437	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCN1/C(=C/c2ccc3cc(C)ccc3[n+]2CC)Sc2ccc3sccc3c21.[I-]		CHEMBL1318350	=	EC50	nM	120.0	CHEMBL4079	Homo sapiens	EC50	uM	0.12
active	7348438	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)c1ccccc1-c1ccc(/C=c2\sc3nc4cc(Br)cnc4n3c2=O)o1		CHEMBL1371869	=	EC50	nM	2390.0	CHEMBL4079	Homo sapiens	EC50	uM	2.39
active	7348439	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(CNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1		CHEMBL1730248	=	EC50	nM	700.0	CHEMBL4079	Homo sapiens	EC50	uM	0.7
inactive	7348440	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)c1ccc(-c2ccc(/C=c3/sc4nc5ccccc5n4c3=O)o2)cc1Cl		CHEMBL1982888	=	EC50	nM	9710.0	CHEMBL4079	Homo sapiens	EC50	uM	9.71
inactive	7348441	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOc1ccc(CCNC(=O)C2CC(C)=CCC2C(=O)O)cc1OCC		CHEMBL1406996	=	EC50	nM	51290.0	CHEMBL4079	Homo sapiens	EC50	uM	51.29
inactive	7348442	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(OC)cc1		CHEMBL1402172	=	EC50	nM	17780.0	CHEMBL4079	Homo sapiens	EC50	uM	17.78
active	7348443	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCOC(=O)CC(NS(=O)(=O)c1ccc2ncc(C(=O)O)c(O)c2c1)c1ccc(OCC)c(OC)c1		CHEMBL1383966	=	EC50	nM	3620.0	CHEMBL4079	Homo sapiens	EC50	uM	3.62
active	7348444	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(c1ccccc1)c1c2c(cc3sc4ccccc4[n+]13)-c1cccc3cccc-2c13.[Br-]		CHEMBL1502014	=	EC50	nM	60.0	CHEMBL4079	Homo sapiens	EC50	uM	0.06
active	7348445	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CCCC[N+](C)(C)CCC(=O)NC(C)(C)CS(=O)(=O)[O-]		CHEMBL1384323	=	EC50	nM	4530.0	CHEMBL4079	Homo sapiens	EC50	uM	4.53
inactive	7348446	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@H](C(N)=O)N(C(=O)/C=C/C)C3)c1		CHEMBL1510349	=	EC50	nM	21280.0	CHEMBL4079	Homo sapiens	EC50	uM	21.28
inactive	7348447	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@@H](C(N)=O)N(C(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)C3)c1		CHEMBL1353369	=	EC50	nM	10620.0	CHEMBL4079	Homo sapiens	EC50	uM	10.62
active	7348448	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	C=C(C)C(=O)Nc1cccc(C2=NOC3(C2)C[C@@H](C(N)=O)N(C(=O)c2ccc(Cl)cc2)C3)c1		CHEMBL1542453	=	EC50	nM	730.0	CHEMBL4079	Homo sapiens	EC50	uM	0.73
active	7348449	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	CC(C)(CS(=O)(=O)[O-])NC(=O)CC[N+](C)(C)CCO		CHEMBL1533230	=	EC50	nM	670.0	CHEMBL4079	Homo sapiens	EC50	uM	0.67
active	7348450	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(CSc1nc2ccccc2c(=O)n1-c1ccccc1)NC(=O)CN1CCCC1=O		CHEMBL1581471	=	EC50	nM	9420.0	CHEMBL4079	Homo sapiens	EC50	uM	9.42
active	7348451	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	COc1ccc(N2C(=O)/C(=C/c3ccco3)C(=O)NC2=S)cc1		CHEMBL1589514	=	EC50	nM	7830.0	CHEMBL4079	Homo sapiens	EC50	uM	7.83
inactive	7348452	CHEMBL1738419	PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]	B	O=C(O)c1ccc(-n2cccc2/C=C2/SC(=O)N(CC(=O)N3CCCC3)C2=O)cc1		CHEMBL1408747	=	EC50	nM	33040.0	CHEMBL4079	Homo sapiens	EC50	uM	33.04
	12046315	CHEMBL2156645	Inhibition of GRK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-1.4	CHEMBL4079	Homo sapiens	INH	%	-1.4
	12728822	CHEMBL2352896	Inhibition of GRK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL4079	Homo sapiens	Activity	%	94.0
	12729067	CHEMBL2352245	Inhibition of GRK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL4079	Homo sapiens	Activity	%	103.0
	12729949	CHEMBL2352185	Inhibition of GRK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL4079	Homo sapiens	Activity	%	98.0
	12730210	CHEMBL2352896	Inhibition of GRK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4079	Homo sapiens	Activity	%	99.0
	13375951	CHEMBL2406112	Inhibition of ADRBK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL4079	Homo sapiens	INH	%	6.0
	13474457	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2435842	=	Inhibition	%	47.6	CHEMBL4079	Homo sapiens	INH	%	47.6
	13474458	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840	=	Inhibition	%	49.6	CHEMBL4079	Homo sapiens	INH	%	49.6
	13474459	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC1=O		CHEMBL2435841	=	Inhibition	%	47.8	CHEMBL4079	Homo sapiens	INH	%	47.8
	13474460	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC1=O		CHEMBL2435837	=	Inhibition	%	37.2	CHEMBL4079	Homo sapiens	INH	%	37.2
	13474461	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC1=O		CHEMBL2435838	=	Inhibition	%	36.3	CHEMBL4079	Homo sapiens	INH	%	36.3
	13474462	CHEMBL2439248	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes at 1 uM incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC(C)C[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O		CHEMBL2435839	=	Inhibition	%	47.2	CHEMBL4079	Homo sapiens	INH	%	47.2
Dose-dependent effect	13474463	CHEMBL2439247	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	13474464	CHEMBL2439247	Inhibition of GRK-2 (unknown origin)-mediated phosphorylation of rhodopsin in bovine-rod outer segment membranes incubated under white light condition for 15 mins measured after 30 mins by autoradiography in presence of [gamma32P]-ATP	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840	=	IC50	nM	340.0	CHEMBL4079	Homo sapiens	IC50	10'-7M	3.4
Active	13474470	CHEMBL2439245	Inhibition of GRK2 in HEK293 cells overexpressing human beta2 adrenergic receptor assessed as increase in beta2 adrenergic receptor density at 1 uM after 1 hr by gamma counting analysis in presence of [125I]cyanopindolol	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
Active	13474471	CHEMBL2439244	Inhibition of GRK2 in HEK293 cells overexpressing human beta2 adrenergic receptor assessed as effect on cAMP production at 1 uM after 1 hr by enzyme immunoassay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
Active	13474472	CHEMBL2439243	Inhibition of GRK2 in HEK293 cells overexpressing human beta2 adrenergic receptor assessed as effect on isoproterenol-induced cAMP production at 1 uM preincubated for 1 hr prior to isoproterenol-stimulation measured after 15 mins by enzyme immunoassay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)O		CHEMBL2435840		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	13842888	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	COc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1-c1ccc2cn[nH]c2c1		CHEMBL3093257	=	IC50	nM	9160.0	CHEMBL4079	Homo sapiens	IC50	uM	9.16
	13842889	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Cc1c(O)ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc12		CHEMBL2079349	=	IC50	nM	13000.0	CHEMBL4079	Homo sapiens	IC50	uM	13.0
	13842890	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Cc1cc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2cc1O		CHEMBL2079395	=	IC50	nM	2140.0	CHEMBL4079	Homo sapiens	IC50	uM	2.14
	13842891	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CCc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1O		CHEMBL3093256	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842892	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	COc1ccc(-c2c(O)ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc23)cc1		CHEMBL3093255	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842893	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(O)c(-c3ccccc3)c2o1		CHEMBL2079205	=	IC50	nM	9700.0	CHEMBL4079	Homo sapiens	IC50	uM	9.7
	13842894	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(O)c(-c3ccc4cn[nH]c4c3)c2o1		CHEMBL3093254	=	IC50	nM	6500.0	CHEMBL4079	Homo sapiens	IC50	uM	6.5
	13842895	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cccc(C(=O)NCCN3CCOCC3)c2)cc1-c1nc2cccc(-c3ccccn3)c2o1		CHEMBL3093253	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842896	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CN(C)COc1cccc(-c2cnc(N)c(-c3nc4cccc(-c5ccccn5)c4o3)c2)c1		CHEMBL3093252	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842897	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CC(C)NC(=O)c1cc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2cc1O		CHEMBL3093251	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842898	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	COc1ccc(-c2ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc3c2)cc1		CHEMBL3093250	=	IC50	nM	3060.0	CHEMBL4079	Homo sapiens	IC50	uM	3.06
	13842899	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CS(=O)(=O)Oc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1		CHEMBL3093249	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842900	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	COc1ccc(C(=O)Nc2ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc3c2)cc1		CHEMBL3093248	=	IC50	nM	3970.0	CHEMBL4079	Homo sapiens	IC50	uM	3.97
	13842901	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(NC(=O)c3ccc(F)cc3)cc2o1		CHEMBL3093247	=	IC50	nM	960.0	CHEMBL4079	Homo sapiens	IC50	uM	0.96
	13842902	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc3c2)cc1		CHEMBL2032290	=	IC50	nM	8300.0	CHEMBL4079	Homo sapiens	IC50	uM	8.3
	13842903	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2o1		CHEMBL3093246	=	IC50	nM	3200.0	CHEMBL4079	Homo sapiens	IC50	uM	3.2
	13842904	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(NC(=O)c3ccccc3)cc2o1		CHEMBL3093245	=	IC50	nM	3190.0	CHEMBL4079	Homo sapiens	IC50	uM	3.19
	13842905	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(NC(=O)Nc3ccccc3)cc2o1		CHEMBL2032286	=	IC50	nM	2630.0	CHEMBL4079	Homo sapiens	IC50	uM	2.63
	13842906	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(NC(=O)Nc3ccc(F)cc3)cc2o1		CHEMBL3093244	=	IC50	nM	1720.0	CHEMBL4079	Homo sapiens	IC50	uM	1.72
	13842907	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	COc1ccc(N(C(=O)Nc2ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc3c2)c2ccccc2)cc1		CHEMBL3093243	=	IC50	nM	660.0	CHEMBL4079	Homo sapiens	IC50	uM	0.66
	13842908	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Nc3ccccn3)cc2o1		CHEMBL3093242	=	IC50	nM	6050.0	CHEMBL4079	Homo sapiens	IC50	uM	6.05
	13842909	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Oc3ncccn3)cc2o1		CHEMBL2079392	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842910	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Oc3ccc(-c4ccccc4)nn3)cc2o1		CHEMBL3093164	=	IC50	nM	3800.0	CHEMBL4079	Homo sapiens	IC50	uM	3.8
	13842911	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	N#Cc1ccnc(Oc2ccc3nc(-c4cc(-c5cnn(C6CCNCC6)c5)cnc4N)oc3c2)c1		CHEMBL3093163	=	IC50	nM	8100.0	CHEMBL4079	Homo sapiens	IC50	uM	8.1
	13842912	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Oc3cc(Cl)ccn3)cc2o1		CHEMBL3093162	=	IC50	nM	17000.0	CHEMBL4079	Homo sapiens	IC50	uM	17.0
	13842913	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Oc3ccc(F)cc3)cc2o1		CHEMBL3093161	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842914	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(OCc3ccc(F)cc3)cc2o1		CHEMBL3093160	=	IC50	nM	11900.0	CHEMBL4079	Homo sapiens	IC50	uM	11.9
	13842915	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(-c3ccc4[nH]ncc4c3)cc2o1		CHEMBL3093159	=	IC50	nM	4050.0	CHEMBL4079	Homo sapiens	IC50	uM	4.05
	13842916	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Oc3ccccc3)cc2o1		CHEMBL3093158	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842917	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(OCc3ccccc3)cc2o1		CHEMBL3093157	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842918	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(-c3cn[nH]c3)cc2o1		CHEMBL3093156	=	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842919	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1		CHEMBL2079397	=	IC50	nM	6200.0	CHEMBL4079	Homo sapiens	IC50	uM	6.2
	13842920	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Nc3cc(F)cc(F)c3)cc2o1		CHEMBL3093155	=	IC50	nM	2260.0	CHEMBL4079	Homo sapiens	IC50	uM	2.26
	13842921	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Nc3c(F)cccc3F)cc2o1		CHEMBL3093154	=	IC50	nM	11500.0	CHEMBL4079	Homo sapiens	IC50	uM	11.5
	13842922	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Nc3ccc(F)cc3)cc2o1		CHEMBL2032289	=	IC50	nM	9300.0	CHEMBL4079	Homo sapiens	IC50	uM	9.3
	13842923	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2o1		CHEMBL3093153	=	IC50	nM	5700.0	CHEMBL4079	Homo sapiens	IC50	uM	5.7
	13842924	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CC(C)Nc1ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc2c1		CHEMBL3093152	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842925	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(N3CCCC3)cc2o1		CHEMBL3093151	=	IC50	nM	460.0	CHEMBL4079	Homo sapiens	IC50	uM	0.46
	13842926	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(N3CCOCC3)cc2o1		CHEMBL3093150	=	IC50	nM	5300.0	CHEMBL4079	Homo sapiens	IC50	uM	5.3
	13842927	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(N3CCCCC3)cc2o1		CHEMBL3093149	=	IC50	nM	10100.0	CHEMBL4079	Homo sapiens	IC50	uM	10.1
	13842928	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2cc(-c3ccccc3)ccc2o1		CHEMBL3093148	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	13842929	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CC(=O)Nc1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL2032299	=	IC50	nM	3060.0	CHEMBL4079	Homo sapiens	IC50	uM	3.06
	13842930	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CCCNc1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL3093147	=	IC50	nM	3190.0	CHEMBL4079	Homo sapiens	IC50	uM	3.19
	13842931	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CN(C)c1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL3093146	=	IC50	nM	8270.0	CHEMBL4079	Homo sapiens	IC50	uM	8.27
	13842932	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CCCCNc1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL3093145	=	IC50	nM	5520.0	CHEMBL4079	Homo sapiens	IC50	uM	5.52
	13842933	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CNc1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL2078645	=	IC50	nM	6320.0	CHEMBL4079	Homo sapiens	IC50	uM	6.32
	13842934	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2cc(Nc3ccccc3)ccc2o1		CHEMBL3093144	=	IC50	nM	4900.0	CHEMBL4079	Homo sapiens	IC50	uM	4.9
	13842935	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	CN(c1ccccc1)c1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL3093261	=	IC50	nM	13000.0	CHEMBL4079	Homo sapiens	IC50	uM	13.0
	13842936	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ccc2oc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nc2c1		CHEMBL2079522	=	IC50	nM	4220.0	CHEMBL4079	Homo sapiens	IC50	uM	4.22
	13842937	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2cc(N3CCCC3)ccc2o1		CHEMBL3093260	=	IC50	nM	1650.0	CHEMBL4079	Homo sapiens	IC50	uM	1.65
	13842938	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2cc(N3CCOCC3)ccc2o1		CHEMBL3093259	=	IC50	nM	6430.0	CHEMBL4079	Homo sapiens	IC50	uM	6.43
	13842939	CHEMBL3096889	Inhibition of GRK-2 (unknown origin) preincubated with enzyme for 10 mins before adding peptide substrate and ATP measured after 1 hr by LANCE-TR-FRET assay	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2cc(N3CCCCC3)ccc2o1		CHEMBL3093258	=	IC50	nM	850.0	CHEMBL4079	Homo sapiens	IC50	uM	0.85
	15018603	CHEMBL3366827	Inhibition of GRK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	8.7	CHEMBL4079	Homo sapiens	INH	%	8.7
	15756973	CHEMBL3630510	Inhibition of GRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	2.3	CHEMBL4079	Homo sapiens	INH	%	2.3
	15757750	CHEMBL3630510	Inhibition of GRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	4.42	CHEMBL4079	Homo sapiens	INH	%	4.42
	15758729	CHEMBL3630510	Inhibition of GRK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	2.91	CHEMBL4079	Homo sapiens	INH	%	2.91
	16357223	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	O=C(CNc1ccc(Cl)c(O)c1)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3716298	=	IC50	nM	4.0	CHEMBL4079	Homo sapiens	IC50	uM	0.004
	16357224	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NCC(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716346	=	IC50	nM	8.3	CHEMBL4079	Homo sapiens	IC50	uM	0.0083
	16357225	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(Nc1ccc(Cl)cc1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3719183	=	IC50	nM	8.0	CHEMBL4079	Homo sapiens	IC50	uM	0.008
	16357226	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NC(C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)c2ccccc2)ccc1Cl		CHEMBL3714810	=	IC50	nM	9.8	CHEMBL4079	Homo sapiens	IC50	uM	0.0098
	16357227	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1cccc(O)c1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3718495	=	IC50	nM	7.8	CHEMBL4079	Homo sapiens	IC50	uM	0.0078
	16357228	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)cc1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3716615	=	IC50	nM	8.8	CHEMBL4079	Homo sapiens	IC50	uM	0.0088
	16357229	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716385	=	IC50	nM	2.0	CHEMBL4079	Homo sapiens	IC50	uM	0.002
	16357230	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CNC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3717041	=	IC50	nM	6.3	CHEMBL4079	Homo sapiens	IC50	uM	0.0063
	16357231	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716440	=	IC50	nM	3.2	CHEMBL4079	Homo sapiens	IC50	uM	0.0032
	16357232	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCNC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1F		CHEMBL3716102	=	IC50	nM	6.4	CHEMBL4079	Homo sapiens	IC50	uM	0.0064
	16357233	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCNC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3719096	=	IC50	nM	4.5	CHEMBL4079	Homo sapiens	IC50	uM	0.0045
	16357234	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(=O)NC2CC2)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716279	=	IC50	nM	8.8	CHEMBL4079	Homo sapiens	IC50	uM	0.0088
	16357235	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1F		CHEMBL3715431	=	IC50	nM	9.3	CHEMBL4079	Homo sapiens	IC50	uM	0.0093
	16357236	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1F		CHEMBL3716850	=	IC50	nM	8.3	CHEMBL4079	Homo sapiens	IC50	uM	0.0083
	16357237	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1cccc(S(N)(=O)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717691	=	IC50	nM	9.3	CHEMBL4079	Homo sapiens	IC50	uM	0.0093
	16357238	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCC(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716786	=	IC50	nM	9.9	CHEMBL4079	Homo sapiens	IC50	uM	0.0099
	16357239	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3719241	=	IC50	nM	8.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0087
	16357240	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(-n2cc[nH]c2=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716599	=	IC50	nM	12.0	CHEMBL4079	Homo sapiens	IC50	uM	0.012
	16357241	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	O=C(Nc1nc2ccc3[nH]ncc3c2s1)C1(Nc2ccc(Cl)cc2)CC1		CHEMBL3718984	=	IC50	nM	3.9	CHEMBL4079	Homo sapiens	IC50	uM	0.0039
	16357243	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCOC(=O)c1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1Cl		CHEMBL3715386	=	IC50	nM	8.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0087
	16357244	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1F		CHEMBL3718067	=	IC50	nM	3.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0037
	16357245	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCC(=O)Nc1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1F		CHEMBL3715310	=	IC50	nM	4.6	CHEMBL4079	Homo sapiens	IC50	uM	0.0046
	16357246	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CNC(=O)c1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1Cl		CHEMBL3717989	=	IC50	nM	7.5	CHEMBL4079	Homo sapiens	IC50	uM	0.0075
	16357247	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	Cc1cc2[nH]ncc2c2sc(NC(=O)C3(Nc4ccc(Cl)cc4)CC3)nc12		CHEMBL3714916	=	IC50	nM	6.2	CHEMBL4079	Homo sapiens	IC50	uM	0.0062
	16357248	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3718650	=	IC50	nM	2.8	CHEMBL4079	Homo sapiens	IC50	uM	0.0028
	16357249	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CCC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3718849	=	IC50	nM	3.9	CHEMBL4079	Homo sapiens	IC50	uM	0.0039
	16357250	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	O=C(Nc1nc2ccc3[nH]ncc3c2s1)C(CO)Nc1ccc(Cl)cc1		CHEMBL3716137	=	IC50	nM	7.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0077
	16357251	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3719041	=	IC50	nM	3.2	CHEMBL4079	Homo sapiens	IC50	uM	0.0032
	16357252	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716523	=	IC50	nM	7.9	CHEMBL4079	Homo sapiens	IC50	uM	0.0079
	16357253	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCCCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716175	=	IC50	nM	7.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0077
	16357254	CHEMBL3721218	Inhibition of human recombinant beta-ARK1 expressed in Sf9 cells using biotinated-RRREEEEESAAA substrate and [gamma33P]-ATP incubated for 60 mins by liquid scintillation counting method	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717935	=	IC50	nM	7.7	CHEMBL4079	Homo sapiens	IC50	uM	0.0077
	16358327	CHEMBL3721230	Inhibition of ARBK1 (unknown origin) assessed as reduction in biotinylated bovine tubulin dimer phosphorylation pre-incubated with enzyme for 30 mins followed by incubation with tubulin and [gamma33P]-ATP for 30 mins by scintillation counting method	B	Cn1cc(-c2cc(C(N)=O)nc3[nH]ncc23)c2cc(OCC3CCCNC3)ccc21		CHEMBL3715293	=	IC50	nM	700.0	CHEMBL4079	Homo sapiens	IC50	uM	0.7
	16358328	CHEMBL3721230	Inhibition of ARBK1 (unknown origin) assessed as reduction in biotinylated bovine tubulin dimer phosphorylation pre-incubated with enzyme for 30 mins followed by incubation with tubulin and [gamma33P]-ATP for 30 mins by scintillation counting method	B	Cn1cc(-c2cc(C(N)=O)cc3[nH]ncc23)c2ccccc21		CHEMBL3717114	=	IC50	nM	270.0	CHEMBL4079	Homo sapiens	IC50	uM	0.27
	16358329	CHEMBL3721230	Inhibition of ARBK1 (unknown origin) assessed as reduction in biotinylated bovine tubulin dimer phosphorylation pre-incubated with enzyme for 30 mins followed by incubation with tubulin and [gamma33P]-ATP for 30 mins by scintillation counting method	B	Cn1cc(-c2cc(C(N)=O)nc3[nH]ncc23)c2cc(OCC(N)=O)ccc21		CHEMBL3715563	=	IC50	nM	20.0	CHEMBL4079	Homo sapiens	IC50	uM	0.02
	16358330	CHEMBL3721230	Inhibition of ARBK1 (unknown origin) assessed as reduction in biotinylated bovine tubulin dimer phosphorylation pre-incubated with enzyme for 30 mins followed by incubation with tubulin and [gamma33P]-ATP for 30 mins by scintillation counting method	B	NC(=O)c1cc(-c2cccc(O)c2)c2cn[nH]c2n1		CHEMBL3715801	=	IC50	nM	2100.0	CHEMBL4079	Homo sapiens	IC50	uM	2.1
	16358331	CHEMBL3721230	Inhibition of ARBK1 (unknown origin) assessed as reduction in biotinylated bovine tubulin dimer phosphorylation pre-incubated with enzyme for 30 mins followed by incubation with tubulin and [gamma33P]-ATP for 30 mins by scintillation counting method	B	NC(=O)c1cc(-c2coc3ccccc23)c2cn[nH]c2n1		CHEMBL3717733	=	IC50	nM	1300.0	CHEMBL4079	Homo sapiens	IC50	uM	1.3
	16375734	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3727997	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
Active	16375742	CHEMBL3734292	Inhibition of GRK2 in HEK293 cells overexpressing beta 2 adrenergic receptor assessed as increase in c-AMP accumulation in presence of isoproterenol	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	16375743	CHEMBL3734291	Inhibition of GRK2 in human U2OS cells assessed as inhibition of morphine-induced translocation of arrestin-GFP to mu opioid receptor preincubated for 60 mins by Transfluor assay	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453	=	IC50	nM	150.0	CHEMBL4079	Homo sapiens	IC50	nM	150.0
	16375744	CHEMBL3734290	Inhibition of GRK2 in human U2OS cells assessed as inhibition of isoproterenol-induced translocation of arrestin-GFP to beta 1 adrenergic receptor preincubated for 60 mins by Transfluor assay	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	16375745	CHEMBL3734289	Inhibition of GRK2 in human U2OS cells assessed as inhibition of isoproterenol-induced translocation of arrestin-GFP to beta 2 adrenergic receptor preincubated for 60 mins by Transfluor assay	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453	=	IC50	nM	4000.0	CHEMBL4079	Homo sapiens	IC50	uM	4.0
	16375810	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CN(C)C(=O)Oc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3732030	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375811	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1cc(NCC(=O)N/N=C/c2ccncc2)cc(OC)c1		CHEMBL3727605	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375812	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(Nc1cccc(Oc2ccccc2)c1)C(=O)N/N=C/c1ccncc1		CHEMBL3728327	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375813	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(Nc1cccc(Oc2ccccc2)c1)C(=O)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728963	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375814	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)Nc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728662	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375815	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)Nc2ccccc2)c1)N/N=C/c1ccncc1		CHEMBL3728346	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375816	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)NNCc1ccncc1		CHEMBL3731541	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375817	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccoc1		CHEMBL3731185	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375818	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccsc1		CHEMBL3732370	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375819	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cn1cncc1/C=N/NC(=O)CNc1cccc(Cl)c1		CHEMBL3729126	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375820	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccnc2ccccc12		CHEMBL3729974	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375821	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	C/C(=N\NC(=O)CNc1cccc(C(=O)Nc2ccccc2)c1)c1ccncc1		CHEMBL3732155	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375822	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	C/C(=N\NC(=O)CNc1cccc(Oc2ccccc2)c1)c1ccncc1		CHEMBL3729597	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375823	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C(\C)c2ccncc2)c1		CHEMBL3729044	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375824	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	C/C(=N\NC(=O)CNc1cccc(OCc2ccccc2)c1)c1ccncc1		CHEMBL3731262	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375825	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2cccnc2)c1)N/N=C/c1ccncc1		CHEMBL3728959	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375826	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccc(Oc2cccc(NCC(=O)N/N=C/c3ccncc3)c2)cc1		CHEMBL3731835	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375827	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccc(F)cc2F)c1)N/N=C/c1ccncc1		CHEMBL3732726	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375828	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccc(F)c(F)c2)c1)N/N=C/c1ccncc1		CHEMBL3730343	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375829	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(-n2cccn2)c1)N/N=C/c1ccncc1		CHEMBL3728217	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375830	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1ccc(Oc2cccc(NCC(=O)N/N=C/c3ccncc3)c2)cc1		CHEMBL3728531	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375831	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)Nc2cccnc2)c1)N/N=C/c1ccncc1		CHEMBL3727632	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375832	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)NCCN2CCOCC2)c1)N/N=C/c1ccncc1		CHEMBL3730425	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375833	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(-n2cncn2)c1)N/N=C/c1ccncc1		CHEMBL3732161	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375834	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccc(OC(F)(F)F)cc2)c1)N/N=C/c1ccncc1		CHEMBL3728261	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375835	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccccc1Oc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3728599	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375836	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	NC(=O)c1ccc(NCC(=O)N/N=C/c2ccncc2)cc1		CHEMBL3732856	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375837	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccccc1N1CCCCC1)N/N=C/c1ccncc1		CHEMBL3730001	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375838	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(=O)Nc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728983	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375839	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(I)cc1)N/N=C/c1ccncc1		CHEMBL3730779	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375840	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccccc1Cc1ccccc1)N/N=C/c1ccncc1		CHEMBL3727587	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375841	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(C)c1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3732762	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375842	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3731051	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375843	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3730059	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375844	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCOc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3728265	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375845	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3731691	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375846	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CS(=O)(=O)Nc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3730604	>	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375847	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	NS(=O)(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3731114	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375848	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(C)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3732134	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375849	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	N#Cc1ccc(NCC(=O)N/N=C/c2ccncc2)cc1		CHEMBL3731340	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375850	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3732076	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375851	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(C)Oc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728377	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375852	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(Cl)cc1)N/N=C/c1ccncc1		CHEMBL3731521	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375853	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccc(NCC(=O)N/N=C/c2ccncc2)cc1		CHEMBL3196036	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375854	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C/c1ccncc1		CHEMBL3727728	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375855	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(C(F)(F)F)cc1)N/N=C/c1ccncc1		CHEMBL3727590	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375856	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(F)cc1)N/N=C/c1ccncc1		CHEMBL3728275	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375857	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CNC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729682	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375858	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(F)(F)F)c1)N/N=C/c1ccncc1		CHEMBL3732237	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375859	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(I)c1)N/N=C/c1ccncc1		CHEMBL3729519	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375860	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CSc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3733136	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375861	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C/c1ccncc1		CHEMBL3730555	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375862	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3732001	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375863	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Br)c1)N/N=C/c1ccncc1		CHEMBL3732073	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375864	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728772	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375865	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccccc1)N/N=C/c1ccncc1		CHEMBL3727506	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375866	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	NC(=O)c1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3729453	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375867	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(F)c1)N/N=C/c1ccncc1		CHEMBL3728684	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375868	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	N#Cc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3730458	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375869	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(COc1cccc(Cl)c1)N/N=C/c1ccncc1		CHEMBL3728289	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375870	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccncc1		CHEMBL3728445	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375871	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(Br)cc1)N/N=C/c1ccncc1		CHEMBL3727996	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375872	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccc(Oc2cccc(NCC(=O)N/N=C/c3c(Cl)cncc3Cl)c2)cc1		CHEMBL3729359	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375873	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(-n2cccn2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728290	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375874	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(=O)NCCN2CCOCC2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3732468	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375875	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(OCCN2CCOCC2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3731839	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375876	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(-n2cncn2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3732992	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375877	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccccc1Oc1ccccc1NCC(=O)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3731095	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375878	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccccc1Br)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3732740	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375879	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	NC(=O)c1ccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)cc1		CHEMBL3732113	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375880	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(=O)Nc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3727962	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375881	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCc1ccccc1NCC(=O)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3730611	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375882	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccccc1NCC(=O)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3730286	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375883	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CS(=O)(=O)Nc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3727573	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375884	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CS(=O)(=O)c1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3731537	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375885	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	NS(=O)(=O)c1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3730586	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375886	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCOc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3729412	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375887	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CCc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3731966	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375888	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(C)Oc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3731647	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375889	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(Cl)cc1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3732611	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375890	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1ccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)cc1		CHEMBL3728666	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375891	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CC(C)c1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3733295	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375892	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3731472	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375893	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccc(F)cc1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3727963	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375894	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CNC(=O)c1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3729247	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375895	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(C(F)(F)F)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3729313	>	Ki	nM	10000.0	CHEMBL4079	Homo sapiens	Ki	nM	10000.0
	16375896	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(I)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728259	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375897	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	CSc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3729970	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375898	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	Cc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3729052	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375899	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc([N+](=O)[O-])c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3728097	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375900	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Br)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3730299	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375901	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	COc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3732018	=	Ki	nM	10.0	CHEMBL4079	Homo sapiens	Ki	nM	10.0
	16375902	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(F)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3730250	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375903	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	N#Cc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1		CHEMBL3733170	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16375904	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1ccccc1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3730062	=	Ki	nM	100.0	CHEMBL4079	Homo sapiens	Ki	nM	100.0
	16375905	CHEMBL3734283	Inhibition of human GRK2 after 90 to 120 mins by Kinase-Glo assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1c(Cl)cncc1Cl		CHEMBL3732736	=	Ki	nM	1000.0	CHEMBL4079	Homo sapiens	Ki	nM	1000.0
	16381052	CHEMBL3736785	Inhibition of human recombinant GRK2 by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	530.0	CHEMBL4079	Homo sapiens	IC50	uM	0.53
	16425290	CHEMBL3751094	Inhibition of GRK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	0.8	CHEMBL4079	Homo sapiens	INH	%	0.8
	16431846	CHEMBL3748200	Inhibition of human GRK2 using casein as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	16450856	CHEMBL3762712	Inhibition of GRK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-0.6	CHEMBL4079	Homo sapiens	INH	%	-0.6
	16451720	CHEMBL3762712	Inhibition of GRK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21	Outside typical range	CHEMBL3758602	=	Inhibition	%	-13.6	CHEMBL4079	Homo sapiens	INH	%	-13.6
	16603044	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490	=	IC50	nM	1380.0	CHEMBL4079	Homo sapiens	IC50	uM	1.38
	16603045	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878	=	IC50	nM	20.0	CHEMBL4079	Homo sapiens	IC50	uM	0.02
	16603046	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	IC50	nM	770.0	CHEMBL4079	Homo sapiens	IC50	uM	0.77
	16603047	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)O)c2)NC(=O)N1		CHEMBL3810250	=	IC50	nM	20000.0	CHEMBL4079	Homo sapiens	IC50	uM	20.0
	16603048	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CNC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL3810349	=	IC50	nM	4300.0	CHEMBL4079	Homo sapiens	IC50	uM	4.3
	16603049	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3ccccc3)c2)NC(=O)N1		CHEMBL3808840	=	IC50	nM	690.0	CHEMBL4079	Homo sapiens	IC50	uM	0.69
	16603050	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3cccc(F)c3)c2)NC(=O)N1		CHEMBL3809100	=	IC50	nM	200.0	CHEMBL4079	Homo sapiens	IC50	uM	0.2
	16603051	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3c(F)cccc3F)c2)NC(=O)N1		CHEMBL3808621	=	IC50	nM	220.0	CHEMBL4079	Homo sapiens	IC50	uM	0.22
	16603052	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	COc1ccccc1CNC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL3809965	=	IC50	nM	60.0	CHEMBL4079	Homo sapiens	IC50	uM	0.06
	16603053	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	COc1cccc(CNC(=O)c2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)c1		CHEMBL3810312	=	IC50	nM	420.0	CHEMBL4079	Homo sapiens	IC50	uM	0.42
	16603054	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	COc1ccc(CNC(=O)c2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)cc1		CHEMBL3810073	=	IC50	nM	460.0	CHEMBL4079	Homo sapiens	IC50	uM	0.46
	16603055	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3ccccn3)c2)NC(=O)N1		CHEMBL3808660	=	IC50	nM	150.0	CHEMBL4079	Homo sapiens	IC50	uM	0.15
	16603056	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCCc3ccccn3)c2)NC(=O)N1		CHEMBL3810107	=	IC50	nM	280.0	CHEMBL4079	Homo sapiens	IC50	uM	0.28
	16603057	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCCc3ccncc3)c2)NC(=O)N1		CHEMBL3808565	=	IC50	nM	4800.0	CHEMBL4079	Homo sapiens	IC50	uM	4.8
	16603058	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3nccc4ccccc34)c2)NC(=O)N1		CHEMBL3809796	=	IC50	nM	280.0	CHEMBL4079	Homo sapiens	IC50	uM	0.28
	16603059	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3c(Cl)cccc3Cl)c2)NC(=O)N1		CHEMBL3810271	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	uM	0.13
	16603060	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3c(C)cccc3C)c2)NC(=O)N1		CHEMBL3809913	=	IC50	nM	70.0	CHEMBL4079	Homo sapiens	IC50	uM	0.07
	16603061	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	COc1cccc(OC)c1CNC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL3809020	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	uM	0.13
	16603062	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3c(C(F)(F)F)cccc3C(F)(F)F)c2)NC(=O)N1		CHEMBL3809788	=	IC50	nM	1200.0	CHEMBL4079	Homo sapiens	IC50	uM	1.2
	16603063	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)c2)NC(=O)N1		CHEMBL3808657	=	IC50	nM	2700.0	CHEMBL4079	Homo sapiens	IC50	uM	2.7
	16603064	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3ncccc3C)c2)NC(=O)N1		CHEMBL3809697	=	IC50	nM	1900.0	CHEMBL4079	Homo sapiens	IC50	uM	1.9
	16603065	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCCc3c(C)cccc3C)c2)NC(=O)N1		CHEMBL3808918	=	IC50	nM	230.0	CHEMBL4079	Homo sapiens	IC50	uM	0.23
	16603066	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NCc3c(C)cccc3C)c2)NC(=O)N1		CHEMBL3808499	=	IC50	nM	25000.0	CHEMBL4079	Homo sapiens	IC50	uM	25.0
	16603067	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NCc3c(C(F)(F)F)cccc3C(F)(F)F)c2)NC(=O)N1		CHEMBL3809604	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	16603068	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	COc1cccc(OC)c1CNC(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL3809124	=	IC50	nM	450.0	CHEMBL4079	Homo sapiens	IC50	uM	0.45
	16603069	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)N(C)c2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3c(C)cccc3C)c2)NC(=O)N1		CHEMBL3809584	=	IC50	nM	4600.0	CHEMBL4079	Homo sapiens	IC50	uM	4.6
	16603070	CHEMBL3811360	Inhibition of full length C-terminal hexahistidine tagged GRK2 (unknown origin) S670A mutant expressed in High Five cells using Bac to Bac insect cell expression system using tubulin as substrate by SDS-PAGE method	B	CC1=C(C(=O)Nc2ccc3c(c2)OCO3)C(c2ccc(F)c(C(=O)NCc3ccccn3)c2)NC(=O)N1		CHEMBL3810383	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	16604932	CHEMBL3811374	Inhibition of human GRK2 S670A mutant preincubated for 30 mins using tubulin as substrate followed by ATP addition	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490	=	IC50	nM	1100.0	CHEMBL4079	Homo sapiens	IC50	uM	1.1
	16614487	CHEMBL3816685	Inhibition of human GRK2 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	1.0	CHEMBL4079	Homo sapiens	INH	%	1.0
	16618207	CHEMBL3816347	Inhibition of full length recombinant human His-tagged GRK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4079	Homo sapiens	INH	%	50.0
	16667592	CHEMBL3854624	Ratio of IC50 for human GRK2 S670A mutant-mediated phosphorylation of light-activated bovine rod outer segments to IC50 for human GRK2 S670A mutant-mediated phosphorylation of tubulin	B	Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL1708	=	Ratio IC50		8.0	CHEMBL4079	Homo sapiens	Ratio IC50		8.0
	16667597	CHEMBL3854619	Inhibition of human GRK2 S670A mutant assessed as decrease in phosphorylation of tubulin preincubated for 30 mins followed by ATP addition	B	Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL1708	=	IC50	nM	2500.0	CHEMBL4079	Homo sapiens	IC50	uM	2.5
	16667602	CHEMBL3854614	Inhibition of human GRK2 S670A mutant assessed as decrease in phosphorylation of light-activated bovine rod outer segments preincubated for 30 mins followed by ATP addition	B	Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL1708	=	IC50	nM	19900.0	CHEMBL4079	Homo sapiens	IC50	uM	19.9
	16667603	CHEMBL3854614	Inhibition of human GRK2 S670A mutant assessed as decrease in phosphorylation of light-activated bovine rod outer segments preincubated for 30 mins followed by ATP addition	B	Cl.c1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	Outside typical range	CHEMBL3983673	=	IC50	nM	316200.0	CHEMBL4079	Homo sapiens	IC50	uM	316.2
	16667604	CHEMBL3854614	Inhibition of human GRK2 S670A mutant assessed as decrease in phosphorylation of light-activated bovine rod outer segments preincubated for 30 mins followed by ATP addition	B	Cl.Oc1ccc(OC[C@@H]2CNCC[C@H]2c2ccc(F)cc2)cc1O		CHEMBL3922827	=	IC50	nM	63100.0	CHEMBL4079	Homo sapiens	IC50	uM	63.1
	16667605	CHEMBL3854613	Inhibition of human GRK2 S670A mutant assessed as decrease in phosphorylation of light-activated bovine rod outer segments after 5 mins by SDS-PAGE analysis	B	Cl.O=C1NCc2ccc(OC[C@@H]3CNCC[C@H]3c3ccc(F)cc3)cc21		CHEMBL3894846	=	IC50	nM	6300.0	CHEMBL4079	Homo sapiens	IC50	uM	6.3
	16837421	CHEMBL3876092	Inhibition of human recombinant full length His-tagged ADRBK1 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
Inactive	17882234	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882235	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882236	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882237	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882238	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882239	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882240	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882241	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882242	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Active	17882243	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	4859.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	4859.0
Inactive	17882244	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882245	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882246	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882247	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882248	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882249	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882250	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882251	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882252	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882253	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882254	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882255	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882256	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882257	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882258	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882259	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882260	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882261	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882262	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882263	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882264	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882265	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882266	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882267	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882268	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882269	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882270	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882271	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882272	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882273	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882274	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882275	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882276	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882277	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882278	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882279	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Active	17882280	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	3558.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	3558.0
Inactive	17882281	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882282	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882283	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882284	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882285	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882286	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882287	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882288	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882289	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882290	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882291	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882292	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882293	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882294	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882295	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882296	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882297	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882298	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882299	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882300	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882301	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882302	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882303	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882304	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882305	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882306	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882307	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882308	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882309	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882310	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882311	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882312	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882313	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882314	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882315	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882316	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882317	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882318	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882319	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882320	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882321	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882322	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882323	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882324	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882325	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882326	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882327	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882328	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882329	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882330	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882331	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Active	17882332	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Kd	nM	170.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	170.0
Inactive	17882333	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882334	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882335	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882336	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882337	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882338	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882339	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882340	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882341	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882342	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882343	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882344	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882345	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882346	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882347	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882348	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882349	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882350	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882351	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882352	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882353	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882354	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882355	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882356	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882357	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882358	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882359	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882360	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882361	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882362	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882363	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882364	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882365	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882366	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882367	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882368	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882369	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882370	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882371	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882372	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882373	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882374	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882375	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882376	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882377	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882378	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882379	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882380	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882381	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882382	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882383	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882384	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882385	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882386	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882387	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882388	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882389	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882390	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882391	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882392	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882393	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882394	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882395	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882396	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882397	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882398	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882399	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Active	17882400	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	22494.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	22494.0
Inactive	17882401	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882402	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882403	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882404	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882405	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882406	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882407	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882408	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882409	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882410	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882411	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882412	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882413	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882414	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882415	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882416	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882417	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882418	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882419	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882420	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882421	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882422	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882423	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882424	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882425	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882426	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882427	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882428	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882429	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882430	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882431	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882432	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882433	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882434	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882435	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882436	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882437	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882438	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882439	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882440	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882441	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882442	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882443	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882444	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882445	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882446	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882447	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882448	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882449	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882450	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Active	17882451	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	17728.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	17728.0
Inactive	17882452	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882453	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882454	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882455	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882456	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882457	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882458	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882459	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882460	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882461	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882462	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882463	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882464	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882465	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882466	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882467	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882468	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882469	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882470	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882471	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882472	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882473	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882474	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882475	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882476	CHEMBL3991621	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4079	Homo sapiens	Kd apparent	nM	30000.0
	18114331	CHEMBL4025163	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	18184395	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1ccccc1)N/N=C/c1ccncc1		CHEMBL3727506	=	IC50	nM	1800.0	CHEMBL4079	Homo sapiens	IC50	nM	1800.0
	18184396	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1ccccc1Cl)N/N=C/c1ccncc1		CHEMBL4103971	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184397	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccncc1		CHEMBL3728445	=	IC50	nM	700.0	CHEMBL4079	Homo sapiens	IC50	nM	700.0
	18184398	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1ccc(Cl)cc1)N/N=C/c1ccncc1		CHEMBL3731521	=	IC50	nM	5600.0	CHEMBL4079	Homo sapiens	IC50	nM	5600.0
	18184399	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3730059	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184400	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728772	=	IC50	nM	49.0	CHEMBL4079	Homo sapiens	IC50	nM	49.0
	18184401	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccc(NCC(=O)N/N=C/c2ccncc2)cc1		CHEMBL4101520	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184402	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1ccccc1)N/N=C1\CCCc2cnccc21		CHEMBL4100576	=	IC50	nM	1100.0	CHEMBL4079	Homo sapiens	IC50	nM	1100.0
	18184403	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1cccc(NCC(=O)N/N=C2\CCCc3cnccc32)c1		CHEMBL4082559	=	IC50	nM	14.0	CHEMBL4079	Homo sapiens	IC50	nM	14.0
	18184404	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCOc1cccc(NCC(=O)N/N=C2\CCCc3cnccc32)c1		CHEMBL4063621	=	IC50	nM	120.0	CHEMBL4079	Homo sapiens	IC50	nM	120.0
	18184405	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4085247	=	IC50	nM	42.0	CHEMBL4079	Homo sapiens	IC50	nM	42.0
	18184406	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4072224	=	IC50	nM	53.0	CHEMBL4079	Homo sapiens	IC50	nM	53.0
	18184407	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1cccc(C(=O)N2CCOCC2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4092989	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184408	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(CNc1cccc(C(=O)NCc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4082713	=	IC50	nM	20.0	CHEMBL4079	Homo sapiens	IC50	nM	20.0
	18184409	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccc(SCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4100707	=	IC50	nM	1200.0	CHEMBL4079	Homo sapiens	IC50	nM	1200.0
	18184410	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1cccc(OCc2n[nH]c(-c3ccncc3)n2)c1		CHEMBL1563842	=	IC50	nM	4400.0	CHEMBL4079	Homo sapiens	IC50	nM	4400.0
	18184411	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4062560	=	IC50	nM	41.0	CHEMBL4079	Homo sapiens	IC50	nM	41.0
	18184412	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4098243	=	IC50	nM	5700.0	CHEMBL4079	Homo sapiens	IC50	nM	5700.0
	18184413	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccc(CNc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4071201	=	IC50	nM	980.0	CHEMBL4079	Homo sapiens	IC50	nM	980.0
	18184414	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(Nc1nc(-c2ccncc2)n[nH]1)c1ccc(Cl)cc1		CHEMBL4101676	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184415	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(CNCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4083675	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184416	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccc(NCCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4063622	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184417	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4091451	=	IC50	nM	100.0	CHEMBL4079	Homo sapiens	IC50	nM	100.0
	18184418	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccccc1NCc1nc(-c2ccncc2)n[nH]1		CHEMBL4077117	=	IC50	nM	1200.0	CHEMBL4079	Homo sapiens	IC50	nM	1200.0
	18184419	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4062967	=	IC50	nM	160.0	CHEMBL4079	Homo sapiens	IC50	nM	160.0
	18184420	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4082714	=	IC50	nM	440.0	CHEMBL4079	Homo sapiens	IC50	nM	440.0
	18184421	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1ccccc1NCc1nc(-c2ccncc2)n[nH]1		CHEMBL4060836	=	IC50	nM	250.0	CHEMBL4079	Homo sapiens	IC50	nM	250.0
	18184422	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Clc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4093686	=	IC50	nM	140.0	CHEMBL4079	Homo sapiens	IC50	nM	140.0
	18184423	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	NS(=O)(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4072686	=	IC50	nM	44.0	CHEMBL4079	Homo sapiens	IC50	nM	44.0
	18184424	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	NS(=O)(=O)c1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4100891	=	IC50	nM	1200.0	CHEMBL4079	Homo sapiens	IC50	nM	1200.0
	18184425	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(Oc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4074131	=	IC50	nM	300.0	CHEMBL4079	Homo sapiens	IC50	nM	300.0
	18184426	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(COc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4093174	=	IC50	nM	360.0	CHEMBL4079	Homo sapiens	IC50	nM	360.0
	18184427	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(CCOc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4065514	=	IC50	nM	280.0	CHEMBL4079	Homo sapiens	IC50	nM	280.0
	18184428	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	c1ccc(CSc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4064596	=	IC50	nM	290.0	CHEMBL4079	Homo sapiens	IC50	nM	290.0
	18184429	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=S(=O)(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4091566	=	IC50	nM	100.0	CHEMBL4079	Homo sapiens	IC50	nM	100.0
	18184430	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=S(=O)(Cc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4075183	=	IC50	nM	1800.0	CHEMBL4079	Homo sapiens	IC50	nM	1800.0
	18184431	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CNC(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4095595	=	IC50	nM	65.0	CHEMBL4079	Homo sapiens	IC50	nM	65.0
	18184432	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(Nc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4076320	=	IC50	nM	54.0	CHEMBL4079	Homo sapiens	IC50	nM	54.0
	18184433	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082775	=	IC50	nM	6.1	CHEMBL4079	Homo sapiens	IC50	nM	6.1
	18184434	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4101739	=	IC50	nM	38.0	CHEMBL4079	Homo sapiens	IC50	nM	38.0
	18184435	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCCCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4075063	=	IC50	nM	23.0	CHEMBL4079	Homo sapiens	IC50	nM	23.0
	18184436	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CN(Cc1ccccc1)C(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4063713	=	IC50	nM	700.0	CHEMBL4079	Homo sapiens	IC50	nM	700.0
	18184437	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CC(=O)Nc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4085317	=	IC50	nM	65.0	CHEMBL4079	Homo sapiens	IC50	nM	65.0
	18184438	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CC(=O)Nc1cc(NCc2nc(-c3ccncc3)n[nH]2)ccc1Cl		CHEMBL4072308	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	nM	130.0
	18184439	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(Cc1ccccc1)Nc1cc(NCc2nc(-c3ccncc3)n[nH]2)ccc1Cl		CHEMBL4093075	=	IC50	nM	12.0	CHEMBL4079	Homo sapiens	IC50	nM	12.0
	18184440	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)Nc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082805	=	IC50	nM	19.0	CHEMBL4079	Homo sapiens	IC50	nM	19.0
	18184441	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(Cc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1)NCc1ccccc1		CHEMBL4100779	=	IC50	nM	320.0	CHEMBL4079	Homo sapiens	IC50	nM	320.0
	18184442	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cc1cc(-c2n[nH]c(CNc3ccc(Cl)cc3)n2)ccn1		CHEMBL4090612	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	18184443	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cc1cnccc1-c1n[nH]c(CNc2cccc(C(=O)NCc3ccccc3)c2)n1		CHEMBL4062649	=	IC50	nM	42.0	CHEMBL4079	Homo sapiens	IC50	nM	42.0
	18184444	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3CO)n[nH]2)c1		CHEMBL4098177	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	nM	130.0
	18184445	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	OCCc1cnccc1-c1n[nH]c(CNc2ccc(Cl)cc2)n1		CHEMBL4080151	=	IC50	nM	3800.0	CHEMBL4079	Homo sapiens	IC50	nM	3800.0
	18184446	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	NC(=O)OCc1cnccc1-c1n[nH]c(CNc2cccc(C(=O)NCc3ccccc3)c2)n1		CHEMBL4090462	=	IC50	nM	560.0	CHEMBL4079	Homo sapiens	IC50	nM	560.0
	18184447	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CC(=O)Nc1cc(-c2nnc(CNc3cccc(C(=O)NCc4ccccc4C(F)(F)F)c3)n2C)ccn1		CHEMBL4069432	=	IC50	nM	170.0	CHEMBL4079	Homo sapiens	IC50	nM	170.0
	18184448	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CNc1cc(-c2nnc(CNc3cccc(C(=O)NCc4c(F)cccc4F)c3)n2C)ccn1		CHEMBL4066027	=	IC50	nM	62.0	CHEMBL4079	Homo sapiens	IC50	nM	62.0
	18184449	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCc2ccccc2)c1		CHEMBL4095742	=	IC50	nM	67.0	CHEMBL4079	Homo sapiens	IC50	nM	67.0
	18184450	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCCc2ccccc2)c1		CHEMBL4059737	=	IC50	nM	250.0	CHEMBL4079	Homo sapiens	IC50	nM	250.0
	18184451	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCCCc2ccccc2)c1		CHEMBL4088026	=	IC50	nM	110.0	CHEMBL4079	Homo sapiens	IC50	nM	110.0
	18184452	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)n[nH]2)c1		CHEMBL4087117	=	IC50	nM	14.0	CHEMBL4079	Homo sapiens	IC50	nM	14.0
	18184453	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cc1c(-c2ccncc2)n[nH]c1CNc1cccc(C(=O)NCc2ccccc2)c1		CHEMBL4065690	=	IC50	nM	9.9	CHEMBL4079	Homo sapiens	IC50	nM	9.9
	18184454	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)c[nH]2)c1		CHEMBL4067877	=	IC50	nM	21.0	CHEMBL4079	Homo sapiens	IC50	nM	21.0
	18184455	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)on2)c1		CHEMBL4089087	=	IC50	nM	24.0	CHEMBL4079	Homo sapiens	IC50	nM	24.0
	18184456	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)no2)c1		CHEMBL4105466	=	IC50	nM	46.0	CHEMBL4079	Homo sapiens	IC50	nM	46.0
	18184457	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2c[nH]c(-c3ccncc3)n2)c1		CHEMBL4081217	=	IC50	nM	460.0	CHEMBL4079	Homo sapiens	IC50	nM	460.0
	18184458	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4086619	=	IC50	nM	45.0	CHEMBL4079	Homo sapiens	IC50	nM	45.0
	18184459	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)c[nH]2)c1		CHEMBL4104512	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	nM	130.0
	18184460	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2ccn(-c3ccncc3)c2)c1		CHEMBL4078768	=	IC50	nM	1700.0	CHEMBL4079	Homo sapiens	IC50	nM	1700.0
	18184461	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)o2)c1		CHEMBL4096791	=	IC50	nM	67.0	CHEMBL4079	Homo sapiens	IC50	nM	67.0
	18184462	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)no2)c1		CHEMBL4082173	=	IC50	nM	200.0	CHEMBL4079	Homo sapiens	IC50	nM	200.0
	18184463	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)cs2)c1		CHEMBL4100175	=	IC50	nM	160.0	CHEMBL4079	Homo sapiens	IC50	nM	160.0
	18184464	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2csc(-c3ccncc3)n2)c1		CHEMBL4072362	=	IC50	nM	470.0	CHEMBL4079	Homo sapiens	IC50	nM	470.0
	18184465	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2[nH]nc(-c3ccncc3)c2-c2ccccc2)c1		CHEMBL4099309	=	IC50	nM	510.0	CHEMBL4079	Homo sapiens	IC50	nM	510.0
	18184466	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)cc1		CHEMBL4082853	=	IC50	nM	17.0	CHEMBL4079	Homo sapiens	IC50	nM	17.0
	18184467	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1cccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)c1		CHEMBL4060973	=	IC50	nM	12.0	CHEMBL4079	Homo sapiens	IC50	nM	12.0
	18184468	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1		CHEMBL4095659	=	IC50	nM	3.0	CHEMBL4079	Homo sapiens	IC50	nM	3.0
	18184469	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1Cl)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1		CHEMBL4077447	=	IC50	nM	3.9	CHEMBL4079	Homo sapiens	IC50	nM	3.9
	18184470	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)nnc1-c1ccncc1		CHEMBL4063774	=	IC50	nM	45.0	CHEMBL4079	Homo sapiens	IC50	nM	45.0
	18184471	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3cccc(C(F)(F)F)c3)c2)nnc1-c1ccncc1		CHEMBL4091573	=	IC50	nM	39.0	CHEMBL4079	Homo sapiens	IC50	nM	39.0
	18184472	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877	=	IC50	nM	18.0	CHEMBL4079	Homo sapiens	IC50	nM	18.0
	18184473	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)n2C)c1		CHEMBL4075992	=	IC50	nM	44.0	CHEMBL4079	Homo sapiens	IC50	nM	44.0
	18184474	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3Cl)c2)nnc1-c1ccncc1		CHEMBL4061438	=	IC50	nM	12.0	CHEMBL4079	Homo sapiens	IC50	nM	12.0
	18184475	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4083276	=	IC50	nM	7.5	CHEMBL4079	Homo sapiens	IC50	nM	7.5
	18184476	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4070100	=	IC50	nM	32.0	CHEMBL4079	Homo sapiens	IC50	nM	32.0
	18184477	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CC(C)n1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4091067	=	IC50	nM	140.0	CHEMBL4079	Homo sapiens	IC50	nM	140.0
	18184478	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)n2Cc2ccccc2)c1		CHEMBL4091972	=	IC50	nM	370.0	CHEMBL4079	Homo sapiens	IC50	nM	370.0
	18184479	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	COCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4064232	=	IC50	nM	16.0	CHEMBL4079	Homo sapiens	IC50	nM	16.0
	18184480	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc(-c3ccncc3)n2CCO)c1		CHEMBL4071398	=	IC50	nM	5.5	CHEMBL4079	Homo sapiens	IC50	nM	5.5
	18184481	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4072828	=	IC50	nM	1.8	CHEMBL4079	Homo sapiens	IC50	nM	1.8
	18184482	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	O=C(NCc1c(F)cccc1F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4073882	=	IC50	nM	1.7	CHEMBL4079	Homo sapiens	IC50	nM	1.7
	18184483	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4094447	=	IC50	nM	7.8	CHEMBL4079	Homo sapiens	IC50	nM	7.8
	18184484	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL4103972	=	IC50	nM	6.8	CHEMBL4079	Homo sapiens	IC50	nM	6.8
	18184485	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4086046	=	IC50	nM	1.9	CHEMBL4079	Homo sapiens	IC50	nM	1.9
	18184486	CHEMBL4040375	Inhibition of recombinant human N-terminal GST-tagged GRK2 expressed in baculovirus expression system using ulight topo2alpha as substrate preincubated for 60 mins followed by substrate addition measured after 10 mins by Lance TR-FRET assay	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878	=	IC50	nM	1.2	CHEMBL4079	Homo sapiens	IC50	nM	1.2
	18184749	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082775	=	EC50	nM	41000.0	CHEMBL4079	Homo sapiens	EC50	uM	41.0
	18184750	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1	Outside typical range	CHEMBL4086619	=	EC50	nM	1900000.0	CHEMBL4079	Homo sapiens	EC50	uM	1900.0
Not Determined	18184751	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	COc1ccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)cc1		CHEMBL4082853		EC50			CHEMBL4079	Homo sapiens	EC50		
Not Determined	18184752	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	COc1cccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)c1		CHEMBL4060973		EC50			CHEMBL4079	Homo sapiens	EC50		
	18184753	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1		CHEMBL4095659	=	EC50	nM	76000.0	CHEMBL4079	Homo sapiens	EC50	uM	76.0
	18184754	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1ccccc1Cl)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1	Outside typical range	CHEMBL4077447	=	EC50	nM	120000.0	CHEMBL4079	Homo sapiens	EC50	uM	120.0
	18184755	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)nnc1-c1ccncc1	Outside typical range	CHEMBL4063774	=	EC50	nM	930000.0	CHEMBL4079	Homo sapiens	EC50	uM	930.0
	18184756	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3cccc(C(F)(F)F)c3)c2)nnc1-c1ccncc1	Outside typical range	CHEMBL4091573	=	EC50	nM	220000.0	CHEMBL4079	Homo sapiens	EC50	uM	220.0
	18184757	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877	=	EC50	nM	10000.0	CHEMBL4079	Homo sapiens	EC50	uM	10.0
Not Determined	18184758	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)n2C)c1		CHEMBL4075992		EC50			CHEMBL4079	Homo sapiens	EC50		
	18184759	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3Cl)c2)nnc1-c1ccncc1		CHEMBL4061438	=	EC50	nM	33000.0	CHEMBL4079	Homo sapiens	EC50	uM	33.0
	18184760	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	CCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4083276	=	EC50	nM	87000.0	CHEMBL4079	Homo sapiens	EC50	uM	87.0
	18184761	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4070100	=	EC50	nM	26000.0	CHEMBL4079	Homo sapiens	EC50	uM	26.0
	18184762	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	CC(C)n1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4091067	>	EC50	nM	30000.0	CHEMBL4079	Homo sapiens	EC50	uM	30.0
Not Determined	18184763	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)n2Cc2ccccc2)c1		CHEMBL4091972		EC50			CHEMBL4079	Homo sapiens	EC50		
	18184764	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	COCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4064232	=	EC50	nM	45000.0	CHEMBL4079	Homo sapiens	EC50	uM	45.0
	18184765	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc(-c3ccncc3)n2CCO)c1		CHEMBL4071398	=	EC50	nM	12000.0	CHEMBL4079	Homo sapiens	EC50	uM	12.0
	18184766	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4072828	=	EC50	nM	1500.0	CHEMBL4079	Homo sapiens	EC50	uM	1.5
	18184767	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	O=C(NCc1c(F)cccc1F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4073882	=	EC50	nM	23000.0	CHEMBL4079	Homo sapiens	EC50	uM	23.0
	18184768	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4094447	=	EC50	nM	7400.0	CHEMBL4079	Homo sapiens	EC50	uM	7.4
	18184769	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL4103972	>	EC50	nM	30000.0	CHEMBL4079	Homo sapiens	EC50	uM	30.0
	18184770	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4086046	=	EC50	nM	3000.0	CHEMBL4079	Homo sapiens	EC50	uM	3.0
Not Determined	18184771	CHEMBL4040378	Inhibition of human GRK2 expressed in HEK-B2 cells assessed as isoproterenol-stimulated cAMP accumulation preincubation for 20 mins followed by isoproterenol stimulation measured after 20 mins by cAMP ALPHA-screen assay	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878		EC50			CHEMBL4079	Homo sapiens	EC50		
Dose-dependent effect	18184807	CHEMBL4040389	Inhibition of human GRK2 in expressed in HEK-B2 cells assessed as reduction in isoproterenol-stimulated beta2AR internalization preincubated for 20 mins followed by isoproterenol stimulation measured after 30 mins by formalin-based confocal microscopic analysis	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082775		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
Dose-dependent effect	18184808	CHEMBL4040389	Inhibition of human GRK2 in expressed in HEK-B2 cells assessed as reduction in isoproterenol-stimulated beta2AR internalization preincubated for 20 mins followed by isoproterenol stimulation measured after 30 mins by formalin-based confocal microscopic analysis	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	18201855	CHEMBL4043633	Inhibition of GRK2 (unknown origin)	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878	=	IC50	nM	20.0	CHEMBL4079	Homo sapiens	IC50	uM	0.02
	18201856	CHEMBL4043633	Inhibition of GRK2 (unknown origin)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490	=	IC50	nM	1380.0	CHEMBL4079	Homo sapiens	IC50	uM	1.38
	18201857	CHEMBL4043633	Inhibition of GRK2 (unknown origin)	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	IC50	nM	770.0	CHEMBL4079	Homo sapiens	IC50	uM	0.77
	18201858	CHEMBL4043633	Inhibition of GRK2 (unknown origin)	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877	=	IC50	nM	30.0	CHEMBL4079	Homo sapiens	IC50	uM	0.03
	18201859	CHEMBL4043633	Inhibition of GRK2 (unknown origin)	B	COc1cccc(OC)c1CNC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL3809020	=	IC50	nM	130.0	CHEMBL4079	Homo sapiens	IC50	uM	0.13
	18203687	CHEMBL4043974	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	87.0	CHEMBL4079	Homo sapiens	Activity	%	87.0
	18211670	CHEMBL4045639	Inhibition of BARK1 labeling at conserved Lys2 (DLKPANILLDEHGHVR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-12.8	CHEMBL4079	Homo sapiens	INH	%	-12.8
	18211786	CHEMBL4045882	Inhibition of BARK1 labeling at conserved Lys2 (DLKPANILLDEHGHVR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-20.6	CHEMBL4079	Homo sapiens	INH	%	-20.6
	18274776	CHEMBL4118304	Inhibition of BARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILLDEHGHVR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-10.8	CHEMBL4079	Homo sapiens	INH	%	-10.8
	18274777	CHEMBL4118304	Inhibition of BARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILLDEHGHVR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-14.4	CHEMBL4079	Homo sapiens	INH	%	-14.4
	18274778	CHEMBL4118304	Inhibition of BARK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPANILLDEHGHVR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-17.7	CHEMBL4079	Homo sapiens	INH	%	-17.7
	18282089	CHEMBL4120044	Inhibition of recombinant full length His-tagged human GRK2 expressed in baculovirus expression system at 1 uM by FRET relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-2.5	CHEMBL4079	Homo sapiens	INH	%	-2.5
	18282408	CHEMBL4120044	Inhibition of recombinant full length His-tagged human GRK2 expressed in baculovirus expression system at 1 uM by FRET relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.1	CHEMBL4079	Homo sapiens	INH	%	2.1
	18440229	CHEMBL4157053	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	18484185	CHEMBL4185832	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	18484669	CHEMBL4185832	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	90.0	CHEMBL4079	Homo sapiens	Activity	%	90.0
	18507775	CHEMBL4190987	Inhibition of recombinant full-length human GRK2 at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	5.0	CHEMBL4079	Homo sapiens	INH	%	5.0
	18585311	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	COCCCC1CCCCN1C(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4228575	=	IC50	nM	29000.0	CHEMBL4079	Homo sapiens	IC50	uM	29.0
	18585312	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NC(C)CCCC(C)C)c2)NC(=O)N1		CHEMBL4229149	=	IC50	nM	4100.0	CHEMBL4079	Homo sapiens	IC50	uM	4.1
	18585313	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N(CCCO)CCCO)c2)NC(=O)N1		CHEMBL4228314	=	IC50	nM	750.0	CHEMBL4079	Homo sapiens	IC50	uM	0.75
	18585314	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	COC(=O)C1(NC(=O)c2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)CCCCC1		CHEMBL4228896	=	IC50	nM	160.0	CHEMBL4079	Homo sapiens	IC50	uM	0.16
	18585315	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCC(C)CN(CCO)C(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4228055	=	IC50	nM	830.0	CHEMBL4079	Homo sapiens	IC50	uM	0.83
	18585316	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC#CCN(CCCC)C(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4225489	=	IC50	nM	430.0	CHEMBL4079	Homo sapiens	IC50	uM	0.43
	18585317	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N(CCO)CCC(C)C)c2)NC(=O)N1		CHEMBL4226323	=	IC50	nM	1500.0	CHEMBL4079	Homo sapiens	IC50	uM	1.5
	18585318	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CCC(=O)N(CC(C)C)C(C)C)c2)NC(=O)N1		CHEMBL4228272	=	IC50	nM	12000.0	CHEMBL4079	Homo sapiens	IC50	uM	12.0
	18585319	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)N(C)Cc3cc(C)[nH]n3)c2)NC(=O)N1		CHEMBL4229100	=	IC50	nM	1100.0	CHEMBL4079	Homo sapiens	IC50	uM	1.1
	18585320	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCCCCCC(C)NC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4228524	=	IC50	nM	4100.0	CHEMBL4079	Homo sapiens	IC50	uM	4.1
	18585321	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	C#CCN(CC(C)C)C(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4224755	=	IC50	nM	2400.0	CHEMBL4079	Homo sapiens	IC50	uM	2.4
	18585322	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCc1nc(CNC(=O)c2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)no1		CHEMBL4228779	=	IC50	nM	160.0	CHEMBL4079	Homo sapiens	IC50	uM	0.16
	18585323	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCC(C)N3CCCCCC3)c2)NC(=O)N1		CHEMBL4225012	=	IC50	nM	1200.0	CHEMBL4079	Homo sapiens	IC50	uM	1.2
	18585324	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N(CCO)Cc3ccco3)c2)NC(=O)N1		CHEMBL4229039	=	IC50	nM	460.0	CHEMBL4079	Homo sapiens	IC50	uM	0.46
	18585325	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	C#CCN(Cc1ccco1)C(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4228945	=	IC50	nM	920.0	CHEMBL4079	Homo sapiens	IC50	uM	0.92
	18585326	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	COCc1noc(CNC(=O)c2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)n1		CHEMBL4225427	=	IC50	nM	250.0	CHEMBL4079	Homo sapiens	IC50	uM	0.25
	18585327	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NC3CC4CCC3(C)C4(C)C)c2)NC(=O)N1		CHEMBL4224950	=	IC50	nM	4600.0	CHEMBL4079	Homo sapiens	IC50	uM	4.6
	18585328	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N3CCCC(C(C)(C)C)CC3)c2)NC(=O)N1		CHEMBL4225310	=	IC50	nM	3500.0	CHEMBL4079	Homo sapiens	IC50	uM	3.5
	18585329	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CCC(=O)NCc3ncc(C)o3)c2)NC(=O)N1		CHEMBL4227413	=	IC50	nM	4000.0	CHEMBL4079	Homo sapiens	IC50	uM	4.0
	18585330	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N(C)Cc3nc(C)c[nH]3)c2)NC(=O)N1		CHEMBL4226886	=	IC50	nM	2000.0	CHEMBL4079	Homo sapiens	IC50	uM	2.0
	18585331	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCCOC1CCN(C(=O)Cc2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)C1		CHEMBL4227283	=	IC50	nM	1600.0	CHEMBL4079	Homo sapiens	IC50	uM	1.6
	18585332	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NCC3CCN(C4CC4)CC3)c2)NC(=O)N1		CHEMBL4227350	=	IC50	nM	680.0	CHEMBL4079	Homo sapiens	IC50	uM	0.68
	18585333	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NCc3ccc(C#N)nc3)c2)NC(=O)N1		CHEMBL4226496	=	IC50	nM	1400.0	CHEMBL4079	Homo sapiens	IC50	uM	1.4
	18585334	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N3CCOC(CCO)C3)c2)NC(=O)N1		CHEMBL4227611	=	IC50	nM	1500.0	CHEMBL4079	Homo sapiens	IC50	uM	1.5
	18585335	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCC(C)N(C)C(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4226760	=	IC50	nM	44000.0	CHEMBL4079	Homo sapiens	IC50	uM	44.0
	18585336	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3cnc4c(c3)CCC4)c2)NC(=O)N1		CHEMBL4227081	=	IC50	nM	340.0	CHEMBL4079	Homo sapiens	IC50	uM	0.34
	18585337	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NC3CN4CCC3CC4)c2)NC(=O)N1		CHEMBL4225645	=	IC50	nM	500.0	CHEMBL4079	Homo sapiens	IC50	uM	0.5
	18585338	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCC(C)N(CO)C(=O)Cc1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4226820	=	IC50	nM	1900.0	CHEMBL4079	Homo sapiens	IC50	uM	1.9
	18585339	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCCc3c(C)noc3C)c2)NC(=O)N1		CHEMBL4227666	=	IC50	nM	640.0	CHEMBL4079	Homo sapiens	IC50	uM	0.64
	18585340	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CCC1(O)CCCN(C(=O)CCc2cc(C3NC(=O)NC(C)=C3C(=O)Nc3ccc4[nH]ncc4c3)ccc2F)C1		CHEMBL4226551	=	IC50	nM	29000.0	CHEMBL4079	Homo sapiens	IC50	uM	29.0
	18585341	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	COc1ccccc1C(C)NC(=O)c1cc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc3[nH]ncc3c2)ccc1F		CHEMBL4227400	=	IC50	nM	400.0	CHEMBL4079	Homo sapiens	IC50	uM	0.4
	18585342	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NC3CC(=O)N(C)C3)c2)NC(=O)N1		CHEMBL4226287	=	IC50	nM	1900.0	CHEMBL4079	Homo sapiens	IC50	uM	1.9
	18585343	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)NCc3cn4ccccc4n3)c2)NC(=O)N1		CHEMBL4227138	=	IC50	nM	540.0	CHEMBL4079	Homo sapiens	IC50	uM	0.54
	18585344	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CCC(=O)NCC3(C)CCCCC3)c2)NC(=O)N1		CHEMBL4228117	=	IC50	nM	1800.0	CHEMBL4079	Homo sapiens	IC50	uM	1.8
	18585345	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(C(=O)N(C)CC3CCCCO3)c2)NC(=O)N1		CHEMBL4226879	=	IC50	nM	14000.0	CHEMBL4079	Homo sapiens	IC50	uM	14.0
	18585346	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)NCc3cc(C)ccc3C)c2)NC(=O)N1		CHEMBL4224914	=	IC50	nM	1900.0	CHEMBL4079	Homo sapiens	IC50	uM	1.9
	18585347	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N3CCC4CCC(C3)N4C)c2)NC(=O)N1		CHEMBL4229046	=	IC50	nM	2100.0	CHEMBL4079	Homo sapiens	IC50	uM	2.1
	18585348	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CCC(=O)NCCc3ccccc3)c2)NC(=O)N1		CHEMBL4229210	=	IC50	nM	4700.0	CHEMBL4079	Homo sapiens	IC50	uM	4.7
	18585349	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CCC(=O)NCC3(CO)CC3)c2)NC(=O)N1		CHEMBL4227754	=	IC50	nM	3800.0	CHEMBL4079	Homo sapiens	IC50	uM	3.8
	18585350	CHEMBL4223317	Inhibition of GRK2 (unknown origin) preincubated for 10 mins followed by peptide substrate and ATP addition measured after 1 hr by TR-FRET assay	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)c(CC(=O)N3Cc4ccc(C)cc4C3)c2)NC(=O)N1		CHEMBL4225917	=	IC50	nM	200.0	CHEMBL4079	Homo sapiens	IC50	uM	0.2
	18655503	CHEMBL4230732	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	18693986	CHEMBL4253439	Inhibition of recombinant human full length His-tagged GRK2 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-2.0	CHEMBL4079	Homo sapiens	INH	%	-2.0
	18694068	CHEMBL4253521	Inhibition of recombinant human full length His-tagged GRK2 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-1.0	CHEMBL4079	Homo sapiens	INH	%	-1.0
	18751582	CHEMBL4264321	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	91.0	CHEMBL4079	Homo sapiens	Activity	%	91.0
	18892877	CHEMBL4314843	Inhibition of recombinant full-length human GRK2 assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.5	CHEMBL4079	Homo sapiens	Activity	%	102.5
	18937957	CHEMBL4327705	Inhibition of human GRK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.79	CHEMBL4079	Homo sapiens	Activity	%	97.79
	18937958	CHEMBL4327705	Inhibition of human GRK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.63	CHEMBL4079	Homo sapiens	Activity	%	99.63
	18938549	CHEMBL4328069	Inhibition of human GRK2 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4079	Homo sapiens	Activity	%	65.0
	18938927	CHEMBL4328433	Inhibition of human GRK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1440.0	CHEMBL4079	Homo sapiens	IC50	10'-6M	1.44
	18964323	CHEMBL4335099	Inhibition of recombinant full length human GRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	98.0	CHEMBL4079	Homo sapiens	Activity	%	98.0
	18964324	CHEMBL4335099	Inhibition of recombinant full length human GRK2 assessed as residual activity at 1 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL4079	Homo sapiens	Activity	%	101.0
	18971916	CHEMBL4336926	Inhibition of recombinant full length human GRK2 assessed as residual activity at 10 uM using casein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	92.0	CHEMBL4079	Homo sapiens	Activity	%	92.0
Not Active	19039765	CHEMBL4351877	Inhibition of recombinant full-length human GRK2 at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
Active	19041124	CHEMBL4352385	Inhibition of human GRK2 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	19059609	CHEMBL4357910	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	85.0	CHEMBL4079	Homo sapiens	Activity	%	85.0
	19091942	CHEMBL4366416	Inhibition of human GRK2 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	0.16	CHEMBL4079	Homo sapiens	INH	%	0.16
	19144857	CHEMBL4377873	Inhibition of recombinant full-length human GRK2 at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1	Outside typical range	CHEMBL4548580	=	Inhibition	%	-13.0	CHEMBL4079	Homo sapiens	INH	%	-13.0
	19146945	CHEMBL4378846	Inhibition of full length recombinant human GRK2 at 10 uM using casein as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-9.0	CHEMBL4079	Homo sapiens	INH	%	-9.0
	19147867	CHEMBL4379341	Inhibition of recombinant full length human GRK2 using casein as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	uM	10.0
	19159437	CHEMBL4382541	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	19181039	CHEMBL4387250	Inhibition of recombinant full length human His-tagged GRK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	19181265	CHEMBL4387250	Inhibition of recombinant full length human His-tagged GRK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	0.5	CHEMBL4079	Homo sapiens	INH	%	0.5
	19191570	CHEMBL4389260	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	98.0	CHEMBL4079	Homo sapiens	INH	%	98.0
	19191923	CHEMBL4389737	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	96.0	CHEMBL4079	Homo sapiens	INH	%	96.0
	19200179	CHEMBL4391363	Binding affinity to wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4079	Homo sapiens	Activity	%	100.0
	19266438	CHEMBL4405388	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4079	Homo sapiens	INH	%	50.0
	19276002	CHEMBL4408005	Inhibition of recombinant human full length GRK2 at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	19290958	CHEMBL4411097	Displacement of BODIPY TR-ADP from human GRK2 preincubated for 10 mins followed by compound addition and measured after 10 to 15 mins by fluorescence polarization displacement assay	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	IC50	nM	20000.0	CHEMBL4079	Homo sapiens	IC50	uM	20.0
	19290959	CHEMBL4411097	Displacement of BODIPY TR-ADP from human GRK2 preincubated for 10 mins followed by compound addition and measured after 10 to 15 mins by fluorescence polarization displacement assay	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	IC50	nM	6300.0	CHEMBL4079	Homo sapiens	IC50	uM	6.3
	19290960	CHEMBL4411097	Displacement of BODIPY TR-ADP from human GRK2 preincubated for 10 mins followed by compound addition and measured after 10 to 15 mins by fluorescence polarization displacement assay	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	IC50	nM	7900.0	CHEMBL4079	Homo sapiens	IC50	uM	7.9
	19476542	CHEMBL4479690	Inhibition of full-length recombinant human His-tagged ADRBK1 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	610.0	CHEMBL4079	Homo sapiens	IC50	nM	610.0
	19476642	CHEMBL4479690	Inhibition of full-length recombinant human His-tagged ADRBK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	23000.0	CHEMBL4079	Homo sapiens	IC50	nM	23000.0
	19476742	CHEMBL4479690	Inhibition of full-length recombinant human His-tagged ADRBK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	160.0	CHEMBL4079	Homo sapiens	IC50	nM	160.0
	19476842	CHEMBL4479690	Inhibition of full-length recombinant human His-tagged ADRBK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	11000.0	CHEMBL4079	Homo sapiens	IC50	nM	11000.0
	20600457	CHEMBL4603292	Inhibition of recombinant full length human His-tagged GRK2 expressed in baculovirus expression system using serine/threonine-16 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	20651774	CHEMBL4615954	Inhibition of human GRK2 in presence of ATP	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12		CHEMBL4640019	=	IC50	nM	11.0	CHEMBL4079	Homo sapiens	IC50	uM	0.011
	22391740	CHEMBL4666986	Inhibition of recombinant human His-tagged full length GRK2 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	3.0	CHEMBL4079	Homo sapiens	INH	%	3.0
	22391741	CHEMBL4666986	Inhibition of recombinant human His-tagged full length GRK2 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	8.0	CHEMBL4079	Homo sapiens	INH	%	8.0
	22391742	CHEMBL4666986	Inhibition of recombinant human His-tagged full length GRK2 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	22392063	CHEMBL4667158	Inhibition of recombinant human His-tagged full length GRK2 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-0.5	CHEMBL4079	Homo sapiens	INH	%	-0.5
	22423587	CHEMBL4674369	Inhibition of human GRK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	100.56	CHEMBL4079	Homo sapiens	Activity	%	100.56
	22423588	CHEMBL4674369	Inhibition of human GRK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	98.97	CHEMBL4079	Homo sapiens	Activity	%	98.97
	22768202	CHEMBL4703613	Binding affinity to full length human GRK2 by Thermofluor thermal shift assay	B	O=c1c2ccc(-c3cn[nH]c3)cc2ncn1Cc1ccccc1		CHEMBL4788026	=	Kd	nM	3330.0	CHEMBL4079	Homo sapiens	Kd	uM	3.33
	22768203	CHEMBL4703613	Binding affinity to full length human GRK2 by Thermofluor thermal shift assay	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490	=	Kd	nM	2980.0	CHEMBL4079	Homo sapiens	Kd	uM	2.98
	22768204	CHEMBL4703613	Binding affinity to full length human GRK2 by Thermofluor thermal shift assay	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878	=	Kd	nM	1.99	CHEMBL4079	Homo sapiens	Kd	nM	1.99
	22768205	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2ccc(-c3cn[nH]c3)cc2ncn1Cc1ccccc1		CHEMBL4788026	=	IC50	nM	4100.0	CHEMBL4079	Homo sapiens	IC50	uM	4.1
	22768206	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cncnc3)ccc2ncn1Cc1ccccc1		CHEMBL4776422	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	22768207	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3ccncc3)ccc2ncn1Cc1ccccc1		CHEMBL4742242	=	IC50	nM	25000.0	CHEMBL4079	Homo sapiens	IC50	uM	25.0
	22768208	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3ccn[nH]3)ccc2ncn1Cc1ccccc1		CHEMBL4791786	>	IC50	nM	100000.0	CHEMBL4079	Homo sapiens	IC50	uM	100.0
	22768209	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cn[nH]c3)ccc2ncn1Cc1ccccc1		CHEMBL4740635	=	IC50	nM	95.0	CHEMBL4079	Homo sapiens	IC50	uM	0.095
	22768210	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cn[nH]c3)c(F)cc2ncn1Cc1ccccc1		CHEMBL4755199	=	IC50	nM	278.0	CHEMBL4079	Homo sapiens	IC50	uM	0.278
	22768211	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cn[nH]c3)cc(F)c2ncn1Cc1ccccc1		CHEMBL4793755	=	IC50	nM	472.0	CHEMBL4079	Homo sapiens	IC50	uM	0.47200000000000003
	22768212	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=C(Nc1ccc(F)cc1)c1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4785990	=	IC50	nM	9.0	CHEMBL4079	Homo sapiens	IC50	uM	0.009000000000000001
	22768213	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=C(NCc1ccc(F)cc1)c1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4760734	<	IC50	nM	10.0	CHEMBL4079	Homo sapiens	IC50	uM	0.01
	22768214	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=C(NCc1c(F)cccc1F)c1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4745381	<	IC50	nM	10.0	CHEMBL4079	Homo sapiens	IC50	uM	0.01
	22768215	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=C(NCc1c(F)cccc1F)c1ccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)cc1		CHEMBL4790114	=	IC50	nM	20000.0	CHEMBL4079	Homo sapiens	IC50	uM	20.0
	22768216	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cn[nH]c3)ccc2ncn1Cc1cccc(Oc2ccc(F)cc2)c1		CHEMBL4752236	=	IC50	nM	78.0	CHEMBL4079	Homo sapiens	IC50	uM	0.078
	22768217	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	O=c1c2cc(-c3cn[nH]c3)ccc2ncn1Cc1cccc(OC(F)F)c1		CHEMBL4782250	=	IC50	nM	206.0	CHEMBL4079	Homo sapiens	IC50	uM	0.20600000000000002
	22768218	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	IC50	nM	19.0	CHEMBL4079	Homo sapiens	IC50	uM	0.019
	22768219	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	COc1cc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)ccc1F		CHEMBL4751285	=	IC50	nM	18.0	CHEMBL4079	Homo sapiens	IC50	uM	0.018000000000000002
	22768220	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	COc1ccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)cc1F		CHEMBL4783892	=	IC50	nM	2750.0	CHEMBL4079	Homo sapiens	IC50	uM	2.75
	22768221	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	COc1cccc([C@@H](C)n2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4782910	=	IC50	nM	13.0	CHEMBL4079	Homo sapiens	IC50	uM	0.013000000000000001
	22768222	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	COc1cccc([C@H](C)n2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4762347	=	IC50	nM	2110.0	CHEMBL4079	Homo sapiens	IC50	uM	2.11
	22768223	CHEMBL4703614	Inhibition of human GRK2 by transcreener assay	B	CNCCC(c1cccc(OC)c1)n1cnc2ccc(-c3cn[nH]c3)cc2c1=O		CHEMBL4753687	=	IC50	nM	12.0	CHEMBL4079	Homo sapiens	IC50	uM	0.012
Active	22768273	CHEMBL4703631	Inhibition of human GRK2 overexpressed in HEK293 cells assessed as enhancement of beta adrenergic receptor mediated isoproterenol-induced cAMP production	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858		Inhibition	%		CHEMBL4079	Homo sapiens	INH		
	22768274	CHEMBL4703632	Inhibition of GRK2 in synchronously beating human stem cell-derived cardiomyocytes assessed as increase in beating rate of the Ca2+ transients measured from baseline at 0.1 uM measured at 27 mins in presence of isoproterenol (Rvb = 12 %)	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	Activity	%	18.0	CHEMBL4079	Homo sapiens	Activity	%	18.0
	22768275	CHEMBL4703633	Inhibition of GRK2 in synchronously beating human stem cell-derived cardiomyocytes assessed as increase in beating rate of the Ca2+ transients measured from baseline at 1 uM measured at 27 mins in presence of isoproterenol (Rvb = 12 %)	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	Activity	%	24.0	CHEMBL4079	Homo sapiens	Activity	%	24.0
	22768276	CHEMBL4703634	Inhibition of GRK2 in synchronously beating human stem cell-derived cardiomyocytes assessed as increase in beating rate of the Ca2+ transients measured from baseline at 10 uM measured at 27 mins in presence of isoproterenol (Rvb = 12 %)	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	Activity	%	24.0	CHEMBL4079	Homo sapiens	Activity	%	24.0
	22768285	CHEMBL4703643	Inhibition of human GRK2 by LANCE assay	B	COc1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4742990	=	IC50	nM	6.0	CHEMBL4079	Homo sapiens	IC50	uM	0.006
	22843731	CHEMBL4720717	Inhibition of human GRK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	879.0	CHEMBL4079	Homo sapiens	IC50	10^-7M	8.79
	22844082	CHEMBL4721068	Inhibition of human GRK2 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	99.4	CHEMBL4079	Homo sapiens	Activity	%	99.4
	22844721	CHEMBL4721396	Inhibition of wild-type human full length GRK2 (M1 to L689 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	100.38	CHEMBL4079	Homo sapiens	Activity	%	100.38
	22952851	CHEMBL4766788	Inhibition of recombinant full length human GRK2 assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	94.0	CHEMBL4079	Homo sapiens	Activity	%	94.0
	23120205	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	21800.0	CHEMBL4079	Homo sapiens	IC50	uM	21.8
	23120206	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	22300.0	CHEMBL4079	Homo sapiens	IC50	uM	22.3
	23120207	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-19400.0	CHEMBL4079	Homo sapiens	IC50	uM	-19.4
	23120208	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-5100.0	CHEMBL4079	Homo sapiens	IC50	uM	-5.1
	23120209	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	3900.0	CHEMBL4079	Homo sapiens	IC50	uM	3.9
	23120210	CHEMBL4804348	Inhibition of BARK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	2800.0	CHEMBL4079	Homo sapiens	IC50	uM	2.8
	23121249	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23121250	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23121251	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23121252	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23121253	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23121254	CHEMBL4804530	Inhibition of BARK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL4079	Homo sapiens	INH	%	0.0
	23122595	CHEMBL4804946	Inhibition of human GRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	63.0	CHEMBL4079	Homo sapiens	Activity	%	63.0
	23123290	CHEMBL4805534	Inhibition of human GRK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	83.0	CHEMBL4079	Homo sapiens	Activity	%	83.0
	23124670	CHEMBL4806551	Inhibition of human GRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	88.0	CHEMBL4079	Homo sapiens	Activity	%	88.0
	23124671	CHEMBL4806551	Inhibition of human GRK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	70.0	CHEMBL4079	Homo sapiens	Activity	%	70.0
	23128128	CHEMBL4807851	Inhibition of GRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4079	Homo sapiens	Activity	%	75.0
	23128129	CHEMBL4807851	Inhibition of GRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4079	Homo sapiens	Activity	%	75.0
	23128130	CHEMBL4807851	Inhibition of GRK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4079	Homo sapiens	Activity	%	75.0
	23150949	CHEMBL4810440	Inhibition of human GRK2 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4854871	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	23150950	CHEMBL4810440	Inhibition of human GRK2 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(NCc3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4847703	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
	23150951	CHEMBL4810440	Inhibition of human GRK2 using casein as substrate in presence of [gamma33P]ATP by radiometric hotspot kinase assay	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	>	IC50	nM	10000.0	CHEMBL4079	Homo sapiens	IC50	nM	10000.0
Not Active	23317430	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	98.0	CHEMBL4079	Homo sapiens	% Control	%	98.0
Not Active	23317898	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23318567	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	74.0	CHEMBL4079	Homo sapiens	% Control	%	74.0
Not Active	23319048	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	95.0	CHEMBL4079	Homo sapiens	% Control	%	95.0
Not Active	23319685	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	71.8	CHEMBL4079	Homo sapiens	% Control	%	71.8
Not Active	23320160	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	97.8	CHEMBL4079	Homo sapiens	% Control	%	97.8
Not Active	23320838	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	90.0	CHEMBL4079	Homo sapiens	% Control	%	90.0
Not Active	23321306	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	93.0	CHEMBL4079	Homo sapiens	% Control	%	93.0
Not Active	23321936	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	51.0	CHEMBL4079	Homo sapiens	% Control	%	51.0
Not Active	23322404	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	89.0	CHEMBL4079	Homo sapiens	% Control	%	89.0
Not Active	23323093	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23323561	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	84.0	CHEMBL4079	Homo sapiens	% Control	%	84.0
Not Active	23324415	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	88.1	CHEMBL4079	Homo sapiens	% Control	%	88.1
Not Active	23325050	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	61.0	CHEMBL4079	Homo sapiens	% Control	%	61.0
Not Active	23325518	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	78.0	CHEMBL4079	Homo sapiens	% Control	%	78.0
Not Active	23326165	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	97.0	CHEMBL4079	Homo sapiens	% Control	%	97.0
Not Active	23326633	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23327333	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	56.0	CHEMBL4079	Homo sapiens	% Control	%	56.0
Not Active	23327801	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	80.0	CHEMBL4079	Homo sapiens	% Control	%	80.0
Not Active	23328388	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL4079	Homo sapiens	% Control	%	87.0
Not Active	23328856	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23329356	CHEMBL4881063	GRK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	85.0	CHEMBL4079	Homo sapiens	% residual kinase activity	%	85.0
Not Active	23329802	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23330270	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	92.0	CHEMBL4079	Homo sapiens	% Control	%	92.0
Not Active	23331026	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	66.0	CHEMBL4079	Homo sapiens	% Control	%	66.0
Not Active	23331494	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	83.0	CHEMBL4079	Homo sapiens	% Control	%	83.0
Not Active	23332081	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.8	CHEMBL4079	Homo sapiens	% Control	%	91.8
Not Active	23332547	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	74.5	CHEMBL4079	Homo sapiens	% Control	%	74.5
Not Active	23333265	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	89.0	CHEMBL4079	Homo sapiens	% Control	%	89.0
Not Active	23333904	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	86.0	CHEMBL4079	Homo sapiens	% Control	%	86.0
Not Active	23334372	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23335351	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL4079	Homo sapiens	% Control	%	98.0
Not Active	23335819	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	81.0	CHEMBL4079	Homo sapiens	% Control	%	81.0
Not Active	23336446	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	71.0	CHEMBL4079	Homo sapiens	% Control	%	71.0
Not Active	23336914	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23337509	CHEMBL4881880	ADRBK1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL4079	Homo sapiens	% Ctrl	%	98.5
Not Active	23337995	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	78.0	CHEMBL4079	Homo sapiens	% Control	%	78.0
Not Active	23338463	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	67.0	CHEMBL4079	Homo sapiens	% Control	%	67.0
Not Active	23339075	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	84.0	CHEMBL4079	Homo sapiens	% Control	%	84.0
Not Active	23339543	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	50.0	CHEMBL4079	Homo sapiens	% Control	%	50.0
Slightly Active	23340180	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	48.0	CHEMBL4079	Homo sapiens	% Control	%	48.0
Not Active	23340648	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23341305	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	96.0	CHEMBL4079	Homo sapiens	% Control	%	96.0
Not Active	23341773	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	77.0	CHEMBL4079	Homo sapiens	% Control	%	77.0
Not Active	23342389	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	66.0	CHEMBL4079	Homo sapiens	% Control	%	66.0
Not Active	23342857	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23343487	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23343955	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	98.0	CHEMBL4079	Homo sapiens	% Control	%	98.0
Not Active	23344593	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	75.0	CHEMBL4079	Homo sapiens	% Control	%	75.0
Not Active	23345166	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	83.0	CHEMBL4079	Homo sapiens	% Control	%	83.0
Not Active	23345634	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	51.0	CHEMBL4079	Homo sapiens	% Control	%	51.0
Not Active	23346211	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	97.5	CHEMBL4079	Homo sapiens	% Control	%	97.5
Not Active	23346680	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23347082	CHEMBL4882609	Invitrogen kinase screen (GRK2)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	µM	0.59	CHEMBL4079	Homo sapiens	IC50	µM	0.59
Not Active	23347574	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	79.5	CHEMBL4079	Homo sapiens	% Control	%	79.5
Not Active	23347575	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174	=	Kd	nM	110.0	CHEMBL4079	Homo sapiens	Kd	nM	110.0
Not Active	23347771	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	79.3	CHEMBL4079	Homo sapiens	% Control	%	79.3
Not Active	23348350	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	84.0	CHEMBL4079	Homo sapiens	% Control	%	84.0
Not Active	23348818	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	74.0	CHEMBL4079	Homo sapiens	% Control	%	74.0
Not Active	23349405	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	73.0	CHEMBL4079	Homo sapiens	% Control	%	73.0
Not Active	23350023	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23350491	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	87.0	CHEMBL4079	Homo sapiens	% Control	%	87.0
Not Active	23351096	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	86.0	CHEMBL4079	Homo sapiens	% Control	%	86.0
Not Active	23351564	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	84.0	CHEMBL4079	Homo sapiens	% Control	%	84.0
Not Active	23351958	CHEMBL4882651	ADRBK1 (GRK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.837	CHEMBL4079	Homo sapiens	% Inhibition	%	3.8373
Not Active	23352588	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	86.0	CHEMBL4079	Homo sapiens	% Control	%	86.0
Not Active	23353056	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	68.0	CHEMBL4079	Homo sapiens	% Control	%	68.0
Not Active	23353938	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23354406	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23355138	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23355606	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23356242	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23356710	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23357319	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	80.0	CHEMBL4079	Homo sapiens	% Control	%	80.0
Not Active	23357966	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23358434	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	96.0	CHEMBL4079	Homo sapiens	% Control	%	96.0
Not Active	23359020	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	50.1	CHEMBL4079	Homo sapiens	% Control	%	50.1
Not Active	23359618	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	81.0	CHEMBL4079	Homo sapiens	% Control	%	81.0
Not Active	23360086	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	78.0	CHEMBL4079	Homo sapiens	% Control	%	78.0
Not Active	23360671	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	85.0	CHEMBL4079	Homo sapiens	% Control	%	85.0
Not Active	23361139	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Slightly Active	23361712	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	42.0	CHEMBL4079	Homo sapiens	% Control	%	42.0
Not Active	23362248	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23362716	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23364358	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL4079	Homo sapiens	% Control	%	85.0
Not Active	23364826	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	91.0	CHEMBL4079	Homo sapiens	% Control	%	91.0
Not Active	23365565	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23366108	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	58.0	CHEMBL4079	Homo sapiens	% Control	%	58.0
Not Active	23366698	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23367166	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23367582	CHEMBL4883935	GRK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	83.0	CHEMBL4079	Homo sapiens	% Residual activity with Skepinone-L	%	83.0
Not Active	23368044	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL4079	Homo sapiens	% Control	%	90.0
Not Active	23368512	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	92.0	CHEMBL4079	Homo sapiens	% Control	%	92.0
Not Active	23369111	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23369579	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	57.0	CHEMBL4079	Homo sapiens	% Control	%	57.0
Not Active	23370078	CHEMBL4884322	GRK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	102.0	CHEMBL4079	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23370547	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23371015	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	91.0	CHEMBL4079	Homo sapiens	% Control	%	91.0
Not Active	23371824	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL4079	Homo sapiens	% Control	%	88.0
Not Active	23372292	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	72.0	CHEMBL4079	Homo sapiens	% Control	%	72.0
	23372655	CHEMBL4884620	BARK1 [GRK2(ADR1LGG5)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4079	Homo sapiens	pIC50		6.0
	23373064	CHEMBL4884911	BARK1 [GRK2(ADR1LGG5)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4079	Homo sapiens	pIC50		6.0
	23373425	CHEMBL4885202	BARK1 [GRK2(ADR1LGG5)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4079	Homo sapiens	pIC50		6.0
Not Active	23374987	CHEMBL4885980	GRK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-3.0	CHEMBL4079	Homo sapiens	% Inhibition	%	-3.0
Not Active	23375719	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL4079	Homo sapiens	% Control	%	87.0
Not Active	23376187	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23376764	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	65.0	CHEMBL4079	Homo sapiens	% Control	%	65.0
Not Active	23377233	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	58.0	CHEMBL4079	Homo sapiens	% Control	%	58.0
Not Active	23378092	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	74.0	CHEMBL4079	Homo sapiens	% Control	%	74.0
Not Active	23378560	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	76.0	CHEMBL4079	Homo sapiens	% Control	%	76.0
Not Active	23379727	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	93.0	CHEMBL4079	Homo sapiens	% Control	%	93.0
Not Active	23380195	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	82.0	CHEMBL4079	Homo sapiens	% Control	%	82.0
Not Active	23380889	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	72.0	CHEMBL4079	Homo sapiens	% Control	%	72.0
Not Active	23381537	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23382005	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4079	Homo sapiens	% Control	%	100.0
Not Active	23382629	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	89.0	CHEMBL4079	Homo sapiens	% Control	%	89.0
Slightly Active	23383097	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	31.0	CHEMBL4079	Homo sapiens	% Control	%	31.0
Not Active	23383692	CHEMBL4887346	ADRBK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL4079	Homo sapiens	% Ctrl	%	95.0
Not Active	23384286	CHEMBL4887881	GRK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	1.9	CHEMBL4079	Homo sapiens	% inhibition	%	1.9
Not Active	23385012	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	84.0	CHEMBL4079	Homo sapiens	% Control	%	84.0
Not Active	23385479	CHEMBL4879736	KinomeScan assay: inhibition of GRK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	92.0	CHEMBL4079	Homo sapiens	% Control	%	92.0
